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Abstract	  
As	   the	   factory	   responsible	   for	   producing	   proteins,	   ribosomes	   are	   of	   great	   importance.	   In	  
bacteria,	   ribosomes	   are	   composed	   of	   three	   ribosomal	   RNAs	   (rRNA)	   of	   different	   sizes,	   and	  
around	  50	   ribosomal	  proteins	   (r-­‐protein).	  During	   ribosome	  biogenesis	   in	  bacteria,	   synthesis	  of	  
rRNAs	   and	   r-­‐proteins	   are	   both	   tightly	   regulated	   and	   coordinated	   to	   ensure	   robust	   growth.	   In	  
particular,	  a	  group	  of	  cis-­‐regulatory	  RNA	  elements	  located	  in	  the	  5’	  untranslated	  regions	  or	  the	  
intergenic	   regions	   in	   r-­‐protein	   operons	   are	   responsible	   for	   the	   regulation	   of	   r-­‐protein	  
biosynthesis.	   Based	   on	   the	   fact	   that	   RNA-­‐regulated	   r-­‐protein	   biosynthesis	   is	   essential	   and	  
universal	   in	   bacteria,	   such	   unique	   and	   varied	   regulatory	   RNAs	   could	   provide	   new	   targets	   for	  
antibacterial	   purpose.	   In	   this	   thesis,	  we	   report	   and	   experimentally	   verify	   a	   novel	   r-­‐protein	   L1	  
regulation	  model	  that	  contains	  dual	  L1-­‐binding	  RNA	  motif,	  and	  for	  the	  first	  time,	  a	  S6:S18	  dimer-­‐
binding	   RNA	   structure	   in	   the	   S6	   operon.	   We	   also	   describe	   Escherichia	   coli-­‐based	   and	  
Schizosaccharomyces	  pombe-­‐based	  reporter	  systems	  for	  in	  vivo	  characterization	  of	  RNA-­‐protein	  
interactions.	   So	   far,	   both	   in	   vivo	   systems	   failed	   to	   report	   RNA-­‐protein	   interactions,	   and	   thus	  
need	   further	   tuning.	   In	   addition,	   we	   performed	   phage-­‐display	   to	   select	   for	   regulatory	   RNA-­‐
binding	  small	  peptides	  and	  examined	  their	  effects	  on	  bacteria	  viability.	  One	  selected	  peptide,	  N-­‐
TVNFKLY-­‐C,	  caused	  defective	  growth	  when	  overexpressed	  in	  E.	  coli.	  Yet,	  further	  studies	  must	  be	  
conducted	   to	   verify	   the	  possibility	   that	   bacteria	  were	   killed	  by	  direct	   RNA-­‐peptide	   interaction	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Ribosomal	  protein	  feed-­‐back	  regulation	  in	  bacteria	  
Prokaryotic	  and	  eukaryotic	  ribosomes	  differ	  in	  their	  size,	  composition	  and	  the	  ratio	  of	  ribosomal	  
protein	   to	   ribosomal	   RNA	   (Ramakrishnan	   et	   al.,	   2002;	   Shajani	   et	   al.,	   2011).	   They	   employ	  
different	   mechanisms	   to	   regulate	   and	   coordinate	   the	   biosynthesis	   of	   ribosomal	   RNAs	   and	  
ribosomal	  proteins	  (Nomura,	  1999).	  Unlike	  the	  separate	  and	  direct	  regulation	  of	  both	  rRNA	  and	  
ribosomal	   protein	   syntheses	   in	   eukaryotes,	   in	   bacteria,	   the	   synthesis	   of	   ribosomal	   protein	   is	  
feed-­‐back	  regulated	  in	  response	  to	  rRNA	  synthesis	  (Nomura	  et	  al.,	  1984;	  Nomura,	  1999).	  Genes	  
coding	  for	  ribosomal	  proteins	  in	  bacteria	  are	  typically	  co-­‐located	  in	  the	  genome	  and	  expressed	  
as	  large	  transcriptional	  units	  (operons)	  with	  strong	  translational	  coupling	  (Jaskunas	  et	  al.,	  1977;	  
Lindahl	  et	  al.,	  1977).	  The	  expression	  of	   ribosomal	  proteins	   is	  often	  negatively	   regulated	  at	   the	  
transcriptional	   or	   translational	   level	   by	   one	   or	   more	   of	   the	   operon	   products	   that	   binds	   to	   a	  
structured	   RNA	   at	   the	   5’-­‐UTR	   or	   intergenic	   region	   of	   the	   mRNA	   associated	   with	   the	   operon	  
(Zengel	  et	  al.,	  1994).	  These	  non-­‐coding	  RNAs	  that	  bind	  to	  excess	  ribosomal	  proteins	  are	  termed	  
cis-­‐regulatory	  elements,	  and	  are	  responsible	  for	  keeping	  the	  ribosomal	  RNA	  and	  protein	  levels	  in	  
balance	   (Nomura	   et	   all.,	   1999).	   Structural	   studies	   have	   revealed	   that	   some	   of	   the	   regulatory	  
elements	  possess	  secondary	  structures	  that	  are	  mimicries	  of	  ribosomal	  protein	  binding	  sites	  on	  
rRNAs	   in	  assembled	  ribosomes,	  but	  have	   lower	  binding	  affinity	   to	   the	  same	  ribosomal	  protein	  
(Choonee	   et	   al.,	   2007;	  Guillier	   et	   al.,	   2002;	   Köhrer	   et	   al.,	   1998;	   Serganov	   et	   al.,	   2003).	   A	   free	  
ribosomal	   protein	   preferentially	   binds	   to	   the	   primary	   target,	   ribosomal	   RNA.	   However,	   under	  
conditions	  where	  rRNA	  sites	  are	  completely	  saturated,	  it	  binds	  to	  the	  regulatory	  site	  on	  its	  own	  
mRNA,	   blocking	   further	   ribosomal	   protein	   synthesis,	   and	   normalizing	   the	   disturbed	   balance	  





Ribosomal	  protein	  synthesis	  in	  bacteria	  is	  phylum-­‐specific	  
As	   one	   of	   the	  most	   studied	   bacterial	   species,	   Escherichia	   coli	   has	   12	   distinct	   RNA	   regulatory	  
elements	   that	   control	   the	   synthesis	   of	  more	   than	   half	   of	   its	   ribosomal	   proteins	   (Aseev	   et	   al.,	  
2008;	  Choonee	  et	  al.,	  2007;	  Lindahl	  et	  al.,	  1977;	  Zengel	  et	  al.,	  1994).	  Each	  of	  them	  is	  a	  structure	  
on	   the	   mRNA	   that	   is	   capable	   of	   binding	   to	   a	   ribosomal	   protein	   to	   down-­‐regulate	   gene	  
expression.	   This	   feedback	   regulation	   has	   been	   found	   to	   be	   accomplished	   via	   a	   variety	   of	  
mechanisms.	   For	   example,	   E.	   coli	   S4	   mediates	   expression	   repression	   of	   the	   α	   operon	   by	  
ribosomal	   entrapment	   (Schlax	   et	   al.,	   2001);	   E.	   coli	   L4	   represses	   synthesis	   of	   the	   11-­‐gene	   S10	  
operon	  by	  premature	   transcription	   termination	   (Stelzl	  et	  al.,	  2003);	  E.	  coli	   L20	  down-­‐regulates	  
expression	  of	  itself	  and	  L35	  through	  ribosome-­‐binding	  site	  occlusion	  (Guillier	  et	  all.,	  2002).	  	  
	  
Despite	   the	   fact	   that	   the	   regulation	   of	   ribosomal	   protein	   synthesis	   by	   cis-­‐regulatory	   RNA	  
elements	   is	   universal	   in	   bacteria,	   the	  organization	  of	   operons	   that	   encode	   ribosomal	   proteins	  
and	  the	  distribution	  of	  RNA	  elements	   in	  each	  operon,	  as	  well	  as	  structures	  of	   those	  elements,	  
are	  not	  well	  conserved	  across	  different	  bacteria	  phyla.	  Instead,	  they	  are	  likely	  to	  be	  both	  distinct	  
and	  diverse.	  Comparative	  genomic	  studies	  have	  revealed	  that	  only	  three	  of	  the	  RNA	  regulatory	  
elements	  in	  E.	  coli	  are	  widespread	  across	  the	  bacterial	  world	  (Figure	  2)	  (Fu	  et	  al.,	  2013).	  These	  
three	   widely	   distributed	   RNA	   elements	   bind	   ribosomal	   proteins	   L1,	   L10,	   and	   S2,	   	   and	   most	  
bacteria	   have	   at	   least	   one	   of	   them.	  Moreover,	   these	  wide-­‐spread	   RNAs	   are	   also	   found	   to	   be	  
both	  structurally	  and	  functionally	  conserved.	  For	  example,	  S2	  proteins	  from	  E.	  coli	  can	  interact	  
with	   S2	   regulatory	   RNAs	   from	   Yersinia	   pestis,	   Haemophilus	   influenza	   and	   Pseudomonas	  
aeruginosa,	   all	  of	  which	  are	  also	  under	  Proteobacteria	  phylum	   (Aseev	  et	  al.,	  2008).	  As	   for	   the	  
narrowly	  distributed	  cis-­‐regulatory	  RNA	  elements	  category,	  under	  Proteobacteria	  phylum,	  most	  
of	  them	  can	  be	  found	  in	  only	  4	  orders	  of	  bacteria	  (Figure	  2)	  (Fu	  et	  al.,	  2013).	  In	  addition	  to	  E.	  coli,	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in	   Bacillus	   subtilis,	   a	   representative	   bacteria	   within	   the	   Firmicutes	   phylum,	   RNA	   elements	  
binding	  to	  L20,	  S15	  and	  S4	  proteins	  have	  been	  experimentally	  confirmed	  to	  be	  structurally	  and	  
functionally	  Firmicutes-­‐specific	  (Choonee	  et	  al.,	  2007;	  Grundy	  et	  al.,	  1991;	  Scott	  et	  al.,	  2005).	  For	  
example,	   cis-­‐regulatory	   RNA	   elements	   of	   ribosomal	   protein	   S15	   from	   E.	   coli	   and	   Bacillus	  
stearothermophilus	  are	  distinct	   in	  both	  their	  primary	  sequences	  and	  secondary	  structures,	  and	  
they	   both	   down-­‐regulate	   S15	   expression	   level	   in	   response	   to	   excess	   S15	   in	   their	   respective	  
organisms	   (Philippe	   et	   al.,	   1990;	   Scott	   et	   al.,	   2001).	   However,	   E.	   coli	   S15	   cannot	   bind	   to	  
regulatory	  RNA	  from	  B.	  stearothermophilus	  both	  in	  vitro	  and	  in	  vivo,	  and	  vice	  versa	  (Scott	  et	  al.,	  
2005).	   More	   recent	   comparative	   genomic	   studies	   have	   also	   discovered	   more	   putative	   RNA	  
elements	  that	  are	  only	  found	  within	  the	  Firmicutes	  phylum	  (Weinberg	  et	  al.,	  2007,	  2010;	  Yao	  et	  
al.,	  2007).	  Since	  RNA-­‐based	  regulation	  of	  ribosomal	  proteins	  remain	  vastly	  unexplored	   in	  most	  
Eubacteria,	  more	  similarities	  and	  diversities	  among	  different	  phyla	  will	  be	  exposed	  in	  the	  future,	  	  
providing	  more	  insights	  into	  bacterial	  ribosomal	  protein	  biosynthesis	  and	  bacterial	  evolution.	  
	  
Control	  of	  ribosomal	  protein	  biosythesis	  as	  a	  viable	  antibacterial	  target	  
Considering	  the	  vital	  role	  of	  the	  ribosome	  in	  protein	  biosynthesis,	  it	  is	  an	  important	  antibacterial	  
target	  for	  a	  wide	  variety	  of	  antibiotics	  (Brodersen	  et	  al.,	  2000).	  Currently,	  it	  is	  targeted	  by	  seven	  
different	   classes	   of	   antibiotics	   used	   clinically,	   most	   of	   which	   function	   at	   the	   large	   ribosome	  
subunit	   and	   rRNAs	   (Knowles	   et	   al.,	   2002;	   Yonath,	   2005).	   More	   specifically,	   these	   antibiotics	  
target	   the	   ribosome	   at	   regions	   of	   functional	   importance,	   including	   the	   decoding	   site,	   the	  
peptidyl-­‐transferase	   center	   (PTC)	   and	   the	   protein	   exit	   tunnel.	   They	   are	   designed	   to	   interfere	  
with	  tRNA	  at	  the	  decoding	  site	  (Brodersen	  et	  al.,	  2000),	  as	  well	  as	  at	  the	  PTC	  (Carter	  et	  al.,	  2000),	  
and	  block	   the	  protein	  exit	   tunnel	   (Schlünzen	  et	  al.,	  2001).	  However,	  with	   the	   increased	  use	  of	  
antibiotics,	   pathogenic	   bacteria	   acquiring	   antibiotic	   resistance	  has	  become	  a	   serious	  problem.	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For	  example,	  tetracycline,	  which	  targets	  at	  the	  A	  site	  of	  16S	  rRNA	  on	  the	  small	  subunit,	  was	  of	  
great	  clinical	  importance	  when	  it	  was	  first	  discovered,	  but	  unfortunately	  strains	  of	  bacteria	  with	  
resistance	   to	   these	   drugs	   have	   become	   commonplace,	   limiting	   its	   effectiveness	   (Goldmann,	  
1992;	  Roberts,	  2005).	  At	  the	  same	  time,	  many	  of	  the	  currently	  used	  antibiotics	  have	  insufficient	  
specificity	  toward	  a	  narrow	  group	  of	  bacteria.	  These	  issues	  call	  for	  the	  identification	  of	  new	  drug	  
targets.	  	  
	  
Aside	  from	  targeting	  bacterial	  ribosomes	  at	  the	  rRNAs	  and	  the	  large	  subunit,	  there	  are	  currently	  
no	  antibiotics	  acting	  on	  the	  regulatory	  RNAs	  involved	  in	  the	  biosynthesis	  of	  ribosomal	  proteins.	  
As	  mentioned	  previously,	  cis-­‐regulatory	  RNA	  elements	  regulating	  ribosomal	  protein	  biosynthesis	  
is	   universal	   across	   the	   bacterial	   world.	   Tight	   and	   accurate	   regulation	   is	   essential	   for	   correct	  
ribosome	  assembly,	  thus	  resulting	  in	  robust	  bacteria	  growth	  (Nomura,	  Yates,	  &	  Dean,	  1980).	  In	  
addition	  to	  the	  fact	  that	  growth	  defects	  associated	  with	  deregulation	  of	  ribosomal	  proteins	  led	  
to	   the	   discovery	   of	   cis-­‐regulatory	   RNA	   elements	   in	   E.	   coli	   (Dean	   et	   al.,	   1980),	   we	   have	   also	  
observed	   bacterial	   growth	   defects	   caused	   by	   regulated	   over-­‐expression	   of	   some	   ribosomal	  
proteins	   in	   our	   own	   studies.	   Thus,	   antibiotics	   that	   can	   simulate	   the	   protein-­‐RNA-­‐binding	  
feedback	   regulation	   of	   ribosomal	   protein	   synthesis	   can	   lead	   to	   repressed	   	   ribosomal	   protein	  
gene	   expression,	   and	   consequently	   inhibit	   bacterial	   growth.	   Moreover,	   unlike	   the	   widely	  
distributed	  bacteria	  riboswitches,	  the	  cis-­‐regulatory	  RNA	  elements	  involved	  in	  ribosomal	  protein	  
regulation	  are	  both	  widely	  and	  narrowly	  distributed,	  and	   thus,	   can	  be	  generally	  or	   specifically	  
targeted	  for	  different	  purposes.	  For	  example,	  the	  RNA	  element	  for	  L1	  synthesis	  regulation	  could	  
be	  a	  universal	   target	   for	  anti-­‐bacterial	  pharmaceuticals,	  while	  the	  RNA	  element	  regulating	  S15	  




Objectives	  of	  this	  thesis	  
The	  first	  objective	  of	  this	  thesis	  was	  to	  experimentally	  confirm	  the	  predicted	  Firmicute-­‐specific	  
regulation	  model	  that	  includes	  dual	  L1	  cis-­‐regulatory	  RNA	  element.	  Rapid	  Amplification	  of	  cDNA	  
Ends	  (RACE)	  would	  help	  examine	  the	  transcriptional	  organization	  of	  L1	  operon	  in	  Firmicutes.	  The	  
RNA-­‐L1	  ribosomal	  protein	  interactions	  were	  examined	  in	  vitro	  with	  filter-­‐binding	  assays.	  	  
	  
The	   second	   objective	   was	   to	   experimentally	   validate	   the	   predicted	   S6-­‐operon	   related	   RNA	  
structure.	   Again,	   RACE	   was	   used	   to	   examine	   the	   transcriptional	   organization	   of	   this	   operon.	  
Then	  in	  vitro	  methods	  were	  used	  to	  study	  the	  interaction	  between	  the	  predicted	  RNA	  structure	  
and	   its	   potential	   protein	   partners.	   In	   addition,	   nuclease	   protection	   assays	   and	   SHAPE	   (2’-­‐
hydroxyl	   acylation	   analyzed	   by	   primer	   extension)	   were	   performed	   to	   investigate	   the	   RNA-­‐
protein	  interaction	  dynamics	  and	  to	  identify	  potential	  interaction	  sites.	  	  
	  
The	   third	   objective	   was	   to	   construct	   E.	   coli-­‐based	   and	   Schizosaccharomyces	   pombe-­‐based	  
reporter	   systems	   to	   study	   RNA-­‐protein	   interactions	   in	   vivo	   and	   to	   test	   their	   feasibility	   as	  
potential	  high	  throughput	  screening	  platforms	  for	  RNA-­‐binding	  compounds.	  	  
	  
The	   last	   objective	   of	   this	   thesis	   was	   to	   use	  M13	   phage	   display	   technique	   to	   select	   for	   small	  
peptides	  that	  specifically	  bind	  to	  cis-­‐regulatory	  RNA	  elements	  and	  explore	  the	  use	  of	  such	  RNA	  
elements	   as	   potential	   antibacterial	   targets.	   Selected	   peptides	   were	   tested	   in	   E.	   coli	   for	   their	  















Chapter	  2:	  	  
Ribosomal	  protein	  L1	  operon	  in	  Firmicutes	  bacteria	  carries	  dual	  L1-­‐binding	  sites	   















Ribosomal	  protein	  L1	  regulatory	  models	  
L1	   is	   one	   of	   the	   primary	   RNA-­‐binding	   ribosomal	   proteins	   in	   ribosome	   assembly.	   It	   specifically	  
associates	  with	  23S	  rRNA	  with	  high	  affinity,	  and	  is	  one	  of	  the	  first	  ribosomal	  proteins	  recruited	  
to	   the	   50S	   ribosomal	   subunit	   during	   ribosome	   assembly	   (Köhrer	   et	   al.,	   1998).	   L1	   protein	   is	  
strikingly	  conserved	  among	  most	  Eubacteria	  and	  Archaea	  in	  both	  structure	  and	  function	  (Gourse	  
et	  al.,	  1981;	  Nikulin	  et	  al.,	  2003).	  In	  addition	  to	  the	  interaction	  with	  the	  rRNA,	  L1	  also	  binds	  to	  its	  
own	  mRNA	  through	  a	  conserved	  RNA	  structure,	  acting	  as	  a	   translational	   repressor.	   L1-­‐binding	  
RNAs	  have	  been	  thoroughly	  studied	  in	  both	  E.	  coli	  (Baughman	  et	  al.,	  1984;	  Zengel	  et	  al.,	  1994)	  
and	  some	  Archaea	  species	  (Ameres	  et	  al.,	  2007;	  Köhrer	  et	  al.,	  1998).	  Regulation	  models	  in	  E.	  coli	  
and	   Methanococcus	   containing	   a	   single	   L1-­‐binding	   site	   have	   been	   generated	   from	   previous	  
studies.	   The	   L1-­‐binding	   site	   in	   these	  models	   exhibits	   high	   similarity	   in	   both	   primary	   sequence	  
and	  secondary	  structure	  to	  the	  L1	  binding	  site	  on	  the	  23S	  rRNA	  (Köhrer	  et	  al.,	  1998;	  Kraft	  et	  al.,	  
1999;	  Zengel	  et	  al.,	  1994).	  However,	  the	  genomic	  location	  of	  this	  site	  varies	  (Figure	  3).	  In	  E.	  coli,	  
the	  gene	  coding	  for	  L1,	  rplA,	  is	  preceded	  by	  that	  which	  encodes	  L11,	  rplK.	  The	  two	  genes	  are	  co-­‐
regulated	   and	   the	   L1-­‐binding	   site	   is	   in	   the	   5’-­‐UTR	   preceding	   rplK.	   As	   a	   result,	   in	   response	   to	  
excess	   L1,	   this	   RNA	   element	   interacts	  with	   L1	   and	   inhibits	   translation	   of	   both	   L11	   and	   L1.	   In	  
Archaea,	   rplA	   and	   rplK	   are	  not	  co-­‐located	   in	   the	  genome.	   Instead,	   rplA	   is	   followed	  by	   rplJ	   and	  
rplL	  in	  the	  same	  operon,	  and	  the	  L1-­‐binding	  site	  directly	  precedes	  rplA.	  As	  mentioned	  before,	  L1	  
cis-­‐regulatory	  RNA	   is	  one	  of	   the	   three	  RNA	  elements	   that	  are	  widespread	  across	   the	  bacterial	  
world.	  L1	  RNA	  motifs	   in	  several	  organisms	  have	  been	  experimentally	  proven	  to	  be	  structurally	  
and	  functionally	  equivalent	  to	  each	  other.	  For	  example,	  E.	  coli	  L1	  is	  able	  to	  inhibit	  translation	  of	  
L1	  mRNA	  from	  M.	  vannieli.	  Conversely,	  M.	  vannielii	  L1	  can	  inhibit	  synthesis	  of	  both	  L11	  and	  L1	  




L1	  model	  validation	  
Overview	  of	  the	  consensus	  L1	  RNA	  structure	  
Computational	   studies	   done	   in	   our	   lab	   revealed	   a	   L1-­‐binding	   consensus	   RNA	   structure	   across	  
many	  bacteria	  phyla	  that	  contains	  a	  stem	  (6-­‐12	  bp)	  –loop	  and	  an	  internal	  bulge	  with	  a	  G-­‐A	  pair	  
and	   an	   unpaired	   adenosine	   (Figure	   4)	   (Fu	   et	   al.,	   2013).	   These	   nucleotides	   are	   known	   to	   be	  
involved	   in	   L1-­‐binding	   in	   both	  E.	   coli	   and	  Methanococcus	   Vannielii	   (Zengel,	   1994;	   Kraft	   et	   al.,	  
1999;	   Nevskaya	   et	   al.,	   2006).	   In	   general,	   the	   structure	   of	   this	   consensus	   RNA	   is	   in	   good	  
agreement	  with	  previous	   studies	   (Köhrer	  et	  al.,	  1998;	  Kraft	  et	  al.,	  1999).	   In	  addition,	  our	  data	  
also	  show	  interesting	  distribution	  patterns	  of	  such	  structured	  RNA	  (Figure	  5).	  In	  accordance	  with	  
previous	   studies,	  one	  copy	  of	   the	  RNA	  structure	   is	   found	   in	  Proteobacteria,	   represented	  by	  E.	  
coli	  (Baughman	  et	  al.,	  1984),	  and	  it	  precedes	  rplK,	  whereas	  the	  one	  copy	  found	  in	  Actinobacteria	  
is	   located	   in	   between	   rplK	   and	   rplA,	   similar	   to	   that	   found	   in	   Archaea	   (Hanner	   et	   al.,	   1994).	  
Surprisingly,	   two	   copies	   of	   the	   same	   structure	   are	   found	   in	   approximately	   40%	  of	   Firmicutes,	  
represented	   by	   Geobacillus	   kaustophilus	   and	   Bacillus	   subtilis,	   suggesting	   a	   potential	   novel	  
bacterial	  L1	  regulation	  model.	  
	  
Transcriptional	  organization	  
Since	   our	   predicted	   novel	   L1	   regulation	   model	   has	   two	   copies	   of	   the	   structured	   RNA,	   one	  
preceding	   rplK	   and	   the	   other	   locating	   in	   the	   intergenic	   region	   between	   rplK	   and	   rplA,	   we	  
conducted	   5’	   RACE	   on	   total	   RNA	   extracted	   from	   B.	   subtilis	   to	   investigate	   the	   transcriptional	  
organization	  of	   this	  model.	  Our	   results	   indicate	   that	  rplK	  and	   rplA	  are	  co-­‐transcribed	   from	  the	  
same	  promoter.	   In	  addition,	  almost	  half	  of	   the	  reverse	  transcripts	   include	  both	  predicted	  RNA	  




Both	  RNAs	  interact	  with	  ribosomal	  protein	  L1	  from	  G.	  kaustophilus	  in	  vitro	  
To	  further	  ensure	  that	  the	  dual	  RNA	  structures	  have	  the	  L1-­‐binding	  ability,	  we	  performed	  filter-­‐
binding	   assays	   on	   ribosomal	   protein	   L1	   and	   the	   two	   RNAs	   derived	   from	  G.	   kaustophilus.	   Our	  
results	   show	   that	   L1	   ribosomal	   protein	   binds	   to	   both	   RNA	   structures	   in	   a	   concentration-­‐
dependent	  manner	  (KD	  25-­‐50	  	  nM)	  (Figure	  6)	  (Fu	  et	  al.,	  2013).	  	  
	  
To	   assess	   the	   specificity	   of	   the	  RNA-­‐protein	   interaction,	  we	   also	  made	  mutant	   copies	   of	   both	  
RNAs.	  Previous	  studies	  on	  L1	  regulation	  show	  that	  the	  L1-­‐RNA	  interaction	  can	  be	  destroyed	  by	  
replacing	   two	  guanines	  with	  adenines	   in	   the	  big	  bulge	   region	   (Köhrer	  et	  al.,	  1998;	  Kraft	  et	  al.,	  
1999).	  Our	  data	   support	   the	   same	  specificity	  as	   the	  RNA-­‐protein	   interaction	  was	  abolished	  by	  
substituting	  G5	  and	  G7	  with	  As	  on	  both	  predicted	  RNA	  structures	  (Figure	  6)	  (Fu	  et	  al.,	  2013).	  In	  
general,	   all	   the	   results	   generated	   from	   filter-­‐binding	   assays	   further	   verified	   that	   the	   two	  
predicted	   RNA	   structures	   are	   biologically	   relevant	   and	   both	   are	   involved	   in	   L1	   regulation	   in	  
Firmicutes.	  	  	  	  	  	  	  
	  
Discussion	  
In	   this	   study,	   we	   experimentally	   validated	   a	   novel	   Firmicute-­‐specific	   ribosomal	   protein	   L1	  
regulation	   model	   predicted	   previously	   during	   our	   computational	   study.	   Transcriptional	  
organization	  of	  this	  model	  was	  confirmed	  by	  5’	  RACE	  and	  dual	  RNA-­‐L1	  protein	   interaction	  was	  
confirmed	  by	  filter-­‐binding	  assays.	  
	  
We	   show	   a	   novel	   regulation	   model	   of	   ribosomal	   protein	   L1	   that	   carries	   two	   conserved	   L1-­‐
binding	   RNA	  motifs,	   both	   of	  which	   interact	  with	   L1	   specifically	   in	   vitro.	   This	  model	   is	   seen	   in	  
more	  than	  40%	  Firmicutes	  with	  complete	  genomes	  and	  may	  present	  a	  new	  mechanism	  in	  which	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ribosomal	  protein	  L1	  and	  L11	  ORFs	  are	   in	  the	  operon	  but	  are	  regulated	  separately.	  Despite	   its	  
widespread	   distribution	   and	   universal	   regulation,	   the	   genomic	   locus	   of	   L1-­‐binding	   RNA	   is	   not	  
conserved	  within	  Eubacteria,	  suggesting	  that	  this	  RNA-­‐mediated	  regulation	  might	  have	  evolved	  
from	  multiple	   inventions.	  This	   finding	  broadens	  our	  knowledge	  of	  the	  currently	  known	  models	  
of	  L1	  regulation	  in	  Eubacteria	  and	  Archaea	  (Fu	  et	  al.,	  2013).	  The	  previous	  neglect	  of	  such	  novel	  
model	  may	  be	  due	   to	   the	   small	   size	  and	  minimal	   sequence	   conservation	  of	   the	   L1-­‐interacting	  
motif,	  it	  is	  likely	  that	  there	  are	  other	  undiscovered	  L1-­‐regulation	  models	  associated	  with	  certain	  













































Ribosomal	  proteins	  S6	  and	  S18	  regulation	  
Ribosomal	  proteins	  S6	  and	  S18	  are	  building	  blocks	  of	  the	  30S	  small	  ribosomal	  subunit,	  but	  unlike	  
L1,	   they	   are	   not	   primary	   ribosomal	   proteins.	   They	   are	   recruited	   to	   the	   16S	   rRNA	   following	  
ribosomal	  protein	  S15,	  and	  as	  a	  result,	  interact	  with	  16S	  rRNA	  as	  well	  as	  S15	  (Recht	  et	  al.,	  2001).	  
Previous	  studies	  have	  also	  shown	  that	  S6:S18	  bind	  to	  the	  rRNA	  as	  a	  protein	  dimer	  (Recht	  et	  al.,	  
2001).	   However,	   the	   regulatory	   mechanism	   of	   S6	   and	   S18	   biosynthesis	   is	   still	   unclear.	   In	  
bacterial	  genomes,	  rpsF	  and	  rpsR,	  genes	  coding	  for	  ribosomal	  proteins	  S6	  and	  S18,	  are	  usually	  
located	  in	  the	  same	  operon.	  For	  example,	  in	  E.	  coli	  and	  Thermus	  thermophilus,	  rpsF	  appears	  as	  
the	  first	  gene	  in	  such	  a	  operon,	  followed	  by	  priB,	  rpsR,	  and	  rplL,	  the	  gene	  coding	  for	  ribosomal	  
protein	   L9	   (Figure	   7)	   (Isono	   et	   al.,	   1978).	   In	   bacteria	   under	   Firmicute	   phyla,	   such	   as	   Bacillus	  
subtilus	   and	  Geobacillus	  kaustophilus,	   the	  genomic	   localization	  of	  rpsF	   and	   rpsR	   is	  very	  similar	  
whereas	   rplL	   is	   located	   somewhere	   else	   (Figure	   7)	   (Akanuma	   et	   al.,	   2012).	   Previously,	  
comparative	  genomic	  studies	  have	  shown	  that	  a	  conserved	  RNA	  motif	  can	  be	   found	   in	   the	  5’-­‐
UTR	   region	   of	   the	   S6-­‐related	   operon	   in	   Firmicutes	   (Yao	   et	   al.,	   2007).	   Thus,	   it	   is	   tempting	   to	  
speculate	   that	   such	   RNA	  motif	   is	   another	   cis-­‐regulatory	   RNA	   and	   responsible	   for	   S6	   and	   S18	  
regulation.	  
	  
S6	  model	  validation	  
Overview	  of	  the	  predicted	  S6	  consensus	  RNA	  structure	  
Computational	   studies	   done	   in	   our	   lab	   reveal	   a	   consensus	   RNA	   structure	   at	   the	   5’-­‐UTR	   of	   S6	  
operon	  across	  many	  bacteria	  phyla	   (Figure	  8)	   (Fu	  et	   al.,	   2014).	   The	   consensus	   structure	  has	   a	  
stem-­‐loop	   with	   an	   internal	   bulge	   containing	   a	   conserved	   pair	   of	   cytosines.	   The	   H1	   stem	  
sequesters	  the	  Shine-­‐Dalgarno	  sequence	  and	  the	  H2	  stem	  (5-­‐124	  nt)	  and	  the	  internal	  bulge	  (7-­‐
22	  nt)	  are	  variable	   in	   length.	  The	  proximity	  of	  the	  predicted	  RNA	  structure	  to	  the	  translational	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start	  site	  of	  S6	  ribosomal	  protein	  and	  its	  blocking	  of	  ribosome	  binding	  site	  suggest	  that	  it	  could	  
be	  another	  widely	  distributed	  cis-­‐regulatory	  RNA	  element.	  
	  
Transcriptional	  organization	  
By	  performing	  5’	  RACE	  on	  total	  RNA	  extracted	  from	  B.	  subtilis	  using	  primers	   in	  the	  S6	  and	  S18	  
coding	   regions,	   we	   identified	   a	   transcription	   start	   site	   20-­‐nt	   upstream	   of	   the	   predicted	   RNA	  
structure	  (Figure	  8)	  (Fu	  et	  al.,	  2013);	  we	  also	  verified	  the	  co-­‐transcription	  of	  rpsF,	  ssbA,	  and	  rpsR.	  
In	  addition,	  3’	  RACE	  revealed	  the	  3’	  end	  of	  the	  transcription,	  which	  lies	  22-­‐nt	  downstream	  of	  the	  
stop	  codon	  for	  S18.	  	  
	  
Predicted	  RNA	  structure	  only	  specifically	  interact	  with	  S6:S18	  dimer	  in	  vitro	  
According	   to	   previous	   examples	   of	   RNA-­‐regulated	   ribosomal	   protein	   biosynthesis	   and	   the	  
transcriptional	   organization	   of	   this	   operon,	   we	   speculate	   that	   either	   S6	   or	   S18	   is	   a	   possible	  
protein	  partner	  of	  the	  RNA	  structure.	  Also,	  previous	  studies	  show	  that	  S6	  and	  S18	  ribomosomal	  
proteins	  form	  a	  dimer	  before	  binding	  to	  the	  16S	  rRNA-­‐S15	  complex	  during	  ribosome	  assembly	  
(Recht	  et	  al.,	  2001),	  suggesting	  that	  S6:S18	  dimer	  could	  also	  be	  a	  potential	  binding	  partner.	  The	  
interaction	  between	  B.	  subtilis	  RNA	  and	  G.	  kaustphilus	  S6,	  S18,	  and	  S6:S18	  dimer	  was	  examined	  
by	  Electrophoretic	  Mobility	  Shift	  Assays	  (EMSA).	  The	  RNA	  structure	  transcribed	  from	  B.	  subtilis	  
genome	  was	  truncated	  at	  the	  5’	  end	  (rpsF_5-­‐69).	  However,	  we	  observed	  similar	  binding	  results	  
by	  using	  RNA	  (rpsF_1-­‐69)	  transcribed	  from	  the	  native	  start	  site.	  During	  protein	  purification,	  we	  
found	  it	  difficult	  to	  isolate	  B.	  subtilis	  S18	  due	  to	  its	  insolubility	  and	  small	  size.	  Since	  S6	  and	  S18	  
from	   B.	   subtilis	   and	   G.	   kaustophilus	   share	   75%	   and	   89%	   sequence	   identity,	   we	   think	   it	   is	  
reasonable	  to	  substitute	  B.	  subtilis	  proteins	  with	  G.	  kaustophilus	  proteins	  in	  this	  experiment.	  In	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addition,	  the	  RNA	  motifs	  from	  G.	  kaustophilus	  and	  B.	  subtilis	  are	  identical	  with	  the	  exception	  of	  
minor	  differences	  in	  the	  sequence	  and	  length	  of	  the	  variable	  stem	  H2.	  
	  
Our	  binding	  results	  show	  that	  the	  RNA	  structure	  specifically	  interacts	  with	  the	  S6:S18	  dimer	  with	  
a	   KD	   of	   155	   nM	   (Figure	   9).	   The	   RNA	   structure	   interacts	  with	   S18	   alone	   only	   at	   a	   high	   protein	  
concentration	   (KD	   >	   500	   nM)	  while	   it	   does	   not	   bind	   S6	   alone	   at	   all.	   The	   S6:S18	   binding	   curve	  
exhibits	  a	  high	  Hill	  coefficient	  (4.1)	  possibly	  due	  to	  the	  insolubility	  of	  S18,	  which	  would	  lead	  to	  
aggregation	   of	   the	   dimer	   protein.	   To	   determine	   if	   this	   is	   the	   cause,	   we	   added	   the	   detergent	  
IGEPAL	  CA630	  (0.02%)	  (Recht	  et	  al.,	  2001)	  to	  the	  binding	  buffer,	  but	  observed	  similar	  KD	  and	  Hill	  
coefficient.	   We	   also	   looked	   into	   the	   RNA-­‐dimer	   protein	   interaction	   by	   titrating	   S6	   and	   S18	  
individually	  while	  keeping	  the	  other	  at	  a	  constant	  concentration	  (500	  nM),	  which	  allows	  most	  of	  
the	  S6	  and	  S18	  to	  dimerize	  before	  interacting	  with	  the	  RNA	  structure.	  As	  a	  result,	  we	  observed	  
two	   curves	   with	   much	   smaller	   Hill	   coefficient	   (S6:	   1.45,	   S18:	   1.5)	   compared	   to	   that	   of	   the	  
previous	  dimer	  curve	  (4.1)	  (Figure	  10).	  Also,	  the	  KD	  of	  each	  binding	  curve	   is	   lower	  than	  that	  of	  
the	  dimer	  curve.	  Such	  results	  suggest	  that	  the	  previous	  high	  Hill	  coefficient	  is	  more	  likely	  caused	  
by	  the	  proportion	  of	  incorrectly	  folded	  S6:S18	  dimer	  in	  the	  binding	  reactions.	  
	  
To	  further	   investigate	  the	  specificity	  of	  the	  RNA-­‐S6:S18	   interaction,	  we	  constructed	  six	  mutant	  
RNAs	  that	  have	  varied	  secondary	  structures	  (M1-­‐M6)	  (Figure	  11).	  M2	  completely	  abolished	  the	  
RNA-­‐protein	   interaction,	  whereas	  M1,	  M3,	  and	  M4	  significantly	   impaired	   the	   interaction	   (KD	  >	  
500	  nM).	  Such	  results	  were	  expected,	  since	  M1/2	  and	  M3	  were	  designed	  to	  compromise	  the	  H1	  
stem	   and	   H2	   stem	   respectively,	   whereas	   M4	   loses	   the	   conserved	   cytosine	   pair.	   The	  
compensatory	  mutant	  M6	  rescues	  the	  loss	  of	  binding	  caused	  by	  M1	  and	  M2,	  suggesting	  that	  the	  
H1	  does	  exist	  as	  predicted.	  Interestingly,	  the	  other	  compensatory	  mutant	  M5	  fails	  to	  restore	  the	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loss	  of	  binding	  caused	  by	  M3,	  indicating	  that	  the	  primary	  sequence	  of	  the	  H2	  area	  maybe	  critical	  
for	  protein-­‐binding.	  	  
	  
Nuclease	  protection	  assays	  results	  
As	   the	   next	   step,	   we	   performed	   RNase	   V1	   and	   A	   protection	   assays	   to	   investigate	   the	   RNA	  
secondary	  structure	  and	  identify	  the	  RNA-­‐protein	  interaction	  general	  regions	  (Figure	  12).	  RNase	  
A	   specifically	   cleaves	   single-­‐stranded	   cytosines	   and	  uracils	   and	  RNase	  V1	  only	   cleaves	  double-­‐
stranded	  regions.	  According	  to	  our	  results,	  when	  the	  RNA	  (rpsF_5-­‐69)	  alone	  is	  exposed	  to	  RNase	  
A	  its	  U32,	  C39,	  U43,	  and	  C48	  are	  cleaved,	  which	  is	  similar	  to	  our	  predictions.	  However,	  different	  
from	   our	   predictions,	   no	   cleavage	   is	   observed	   at	   C41,	   U46,	   and	   C47,	   suggesting	   that	   there	   is	  
likely	  tertiary	  structure	  involved	  in	  the	  big	  bulge	  region.	  When	  RNA	  (rpsF_5-­‐69)	  alone	  is	  exposed	  
to	  RNase	  V1,	  cleavage	  is	  seen	  at	  C28-­‐C29	  and	  G35-­‐C38,	  which	  is	  the	  predicted	  H2	  stem,	  as	  well	  
as	  U24-­‐U25	  and	  A52-­‐G56,	  the	  predicted	  H1	  stem.	  In	  addition,	  the	  RNase	  probing	  assays	  with	  the	  
RNA	   mutant	   M4	   alone	   result	   in	   very	   similar	   cleavage	   patterns	   compared	   with	   those	   of	   the	  
wildtype	   RNA,	   suggesting	   that	  mutating	   the	   conserved	   double	   cytosine	   does	   not	   significantly	  
alter	  the	  structure.	  
	  
The	   RNase	   probing	   assays	   can	   also	   provide	   information	   on	   general	   RNA-­‐protein	   interaction	  
regions,	   since	   the	   S6:S18	   dimer	  may	   protect	   the	   RNA	   structure	   from	   RNase	   attack	   at	   certain	  
regions.	   Our	   results	   show	   that	   with	   the	   dimer	   protein	   present,	   protection	   from	   RNase	   V1	   is	  
observed	  at	  C28-­‐C29	  and	  G35-­‐C38,	  suggesting	  that	  the	  RNA	  structure	  might	  have	  direct	  contact	  
with	  the	  dimer	  at	  the	  predicted	  H2	  region	  upon	  protein	  binding.	  Protection	  is	  also	  seen	  at	  A52-­‐
G53,	  which	  is	  the	  H1	  stem.	  These	  results	  indicate	  that	  the	  loss	  of	  binding	  with	  M1/2	  and	  M3	  we	  
observed	  in	  EMSA	  are	  likely	  due	  to	  loss	  of	  the	  stems,	  and	  that	  of	  M5	  is	  probably	  due	  to	  loss	  of	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sequence-­‐specific	  contacts	  between	  the	  mutant	  RNA	  and	  the	  dimer	  protein.	  In	  accordance	  with	  
the	   EMSA	   results,	   there	   is	   no	   sign	   of	   M4-­‐S6:S18	   dimer	   interaction	   in	   RNase	   probing	   assays,	  
suggesting	   that	   the	   conserved	   cytosine	   pair	   is	   critical	   in	   dimer	   binding	   as	   predicted.	  We	   also	  
tested	   the	   RNA-­‐S18	   interaction	   without	   S6	   with	   RNase	   probing	   assays.	   Our	   results	   show	   no	  
cleavage	   change	   even	   at	   high	   S18	   concentration	   (600	   nM),	   suggesting	   that	   the	   RNA:S18	  
interaction	  we	  observed	  with	  EMSA	  might	  be	  too	  weak	  for	  probing	  assays	  to	  detect	  or	  it	  could	  
be	  nonspecific	  interaction	  due	  to	  S18	  aggregation.	  
	  
Selective	  2’-­‐hydroxyl	  acylation	  analyzed	  by	  primer	  extension	  (SHAPE)	  results	  
	  To	  study	  the	  secondary	  structure	  of	  the	  predicted	  RNA,	  we	  also	  conducted	  SHAPE	  on	  protein-­‐
bound	  and	  unbound	  full	  length	  RNAs	  (rpsF_1-­‐69)	  (Figure	  12;	  Figure	  13).	  In	  a	  SHAPE	  experiment,	  
RNA	  is	  treated	  with	  reagents	  such	  as	  N-­‐methylisotoic	  anhydride	  (NMIA),	  which	  selectively	  reacts	  
with	  the	  2’-­‐hydroxyl	  positions	  of	  the	  RNA	  backbone	  at	  conformationally	  flexible	  nucleotides	  to	  
form	   2’-­‐O’-­‐adducts	   (Wilkinson	   et	   al.,	   2006).	   These	   adducts	   are	   then	   detected	   by	   primer	  
extension	   and	   the	   results	   can	   report	   the	   extent	   to	  which	   a	   nucleotide	   is	   constrained	   by	   base	  
pairing	  or	  other	  interactions	  (Deigan	  et	  al.,	  2008).	  Our	  data	  suggest	  similar	  flexibility	  at	  the	  3’	  of	  
the	   RNA	   structure	   in	   both	   states.	   Reactive	   nucleotides	   are	   seen	   at	   the	   predicted	   H1/2	   loop	  
regions,	   the	   big	   bulge	   region,	   and	   the	   3’	   end,	   suggesting	   that	   these	   regions	   indeed	   are	   not	  
structured.	  We	  were	   unable	   to	   quantify	   the	   first	   six	   nucleotides	   of	   the	   RNA	   due	   to	   the	   poor	  
resolution	  at	  the	  5’	  end	  on	  the	  gel.	  In	  addition,	  the	  loss	  of	  nucleotides	  35-­‐39	  quantification	  data	  
is	  due	  to	  a	  strong	  pause	  site	  at	  the	  base	  of	  the	  H2	  stem.	  In	  general,	  the	  structures	  of	  the	  S6:S18-­‐
bound	  and	  the	  unbound	  state	  are	  very	  similar,	  indicating	  that	  the	  RNA	  structure	  is	  not	  formed	  as	  





In	   this	   chapter,	   we	   experimentally	   investigated	   a	   RNA	  motif	   predicted	   to	   be	   associated	   with	  
bacterial	  S6	  operon.	  The	  transcriptional	  organization	  of	  B.	  subtilis	  S6	  operon	  was	  studied	  by	  3’	  
and	  5’	  RACE.	  The	  binding	  partner	  of	  the	  RNA	  motif	  and	  the	  binding	  kinetics	  were	  investigated	  by	  
EMSA.	   The	   secondary	   structure	   of	   the	   predicted	   RNA	   motif	   was	   confirmed	   by	   SHAPE	   and	  
detailed	  RNA-­‐protein	  interaction	  was	  profiled	  by	  nuclease	  protection	  assays.	  
	  
We	   identify	   the	   conserved	   RNA	   motif	   found	   in	   the	   5’-­‐UTR	   region	   of	   S6	   operon	   specifically	  
interacts	   with	   an	   S6:S18	   dimer	   protein	   in	   vitro.	   Ribosomal	   protein	   S18	   is	   insoluble	   and	   only	  
partially	  folded	  without	  binding	  to	  S6	  (Held	  et	  al.,	  1974).	  Although	  we	  observed	  weak	  interaction	  
between	   the	   predicted	   RNA	   	   structure	   and	   S18,	   the	   dissociation	   constant	   is	   high	   (>	   500	   nM)	  
compared	   to	   that	   of	   the	   RNA-­‐S6:S18	   binding	   curve	   (150	   nM).	   In	   addition,	   we	   find	   that	   in	  
nuclease	  protection	  assays,	  S18	  alone	  cannot	  protect	  the	  RNA	  structure	  from	  nuclease	  cleavage,	  
proving	   that	   this	   interaction	   is	   not	   specific	   and	   is	   probably	   the	   result	   of	   insoluble	   S18	  
aggregation.	  The	  dissociation	  constant	  we	  observed	  for	  the	  rpsF_5-­‐69	  and	  S6:S18	  dimer	  binding	  
is	   significantly	  higher	   than	   that	   reported	   for	   the	  16S	   rRNA-­‐S15	  complex	  and	  S6:S18	  binding	   (6	  
nM)	  (Recht	  et	  al.,	  2001).	  The	  difference	  is	  consistent	  with	  many	  previously	  observed	  variations	  
between	   ribosomal	  protein-­‐rRNA	  binding	  and	   ribosomal	  protein-­‐mRNA	  binding.	   It	  also	   fits	   the	  
theory	   that	   when	   ribosomal	   proteins	   are	   expressed	   they	   preferably	   bind	   to	   the	   rRNA	   for	  
ribosome	  assembly	  (Zengel	  et	  al.,	  1994).	  
	  
During	  RNA-­‐S6:18	  dimer	  binding	  titration,	  we	  do	  observe	  a	  steep	  transition	  (Hill	  coefficient	  =	  4.1)	  
between	   the	   unbound	   and	   bound	   states.	   A	   similar	   steep	   transition	   is	   also	   seen	   in	   a	   previous	  
study	   (Recht	   et	   al.,	   2001)	  with	  dissociation	   constants	   of	   S6:S18	  dimerization	   and	   S6:S18-­‐rRNA	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interaction	  close	  to	  each	  other	  (8	  nM	  and	  6	  nM).	  We	  conclude	  that	  the	  steep	  transition	  in	  our	  
study	  is	  due	  to	  a	  similar	  reason,	  which	  is	  the	  inefficient	  formation	  of	  S6:S18	  dimer	  at	  low	  protein	  
concentration	  in	  binding	  buffer.	  This	  conclusion	  is	  supported	  by	  the	  lower	  dissociation	  constant	  
numbers	  observed	  when	  titrating	  S6	  and	  S18	  individually	  while	  holding	  the	  other	  component	  at	  
a	  constant	  high	  concentration	  (500	  nM).	  
	  
Previous	  studies	  as	  well	  as	  our	  computational	  data	  suggest	  that	  a	  pair	  of	  cytosines	  (C47	  and	  C48)	  
are	  very	  conserved	  in	  the	  internal	  bulge	  region	  of	  the	  consensus	  RNA	  structure	  associated	  with	  
S6	  operon	  and	  may	  be	  directly	  involved	  in	  protein-­‐binding	  (Yao	  et	  al.,	  2007).	  Our	  experimental	  
data	  show	  that	  mutating	  the	  cytosine	  pair	  (M4)	  disrupts	  RNA-­‐S6:S18	  interaction	  and	  that	  at	  least	  
one	   cytosine	   (C48)	   is	   protected	   by	   the	   dimer	   protein	   from	   nuclease	   cleavage.	   In	   addition,	   a	  
similar	  cytosine	  pair	  is	  also	  conserved	  in	  >90%	  of	  bacterial	  16S	  rRNA	  sequences	  (Figure	  8)	  and	  is	  
involved	  in	  S18-­‐binding	  during	  ribosome	  assembly	  (Recht	  et	  al.,	  2001).	  Considering	  the	  weak	  but	  
consistent	   interaction	   between	   S18	   and	   rpsF_6-­‐59	   observed	   in	   our	   binding	   assays	   and	   the	  
similarities	  between	  the	  rRNA	  and	  mRNA	  primary	  sequences,	  we	  speculate	  the	  mRNA	  version	  of	  
the	   protein-­‐binding	   structure	   is	   a	   mimic	   of	   the	   rRNA	   version,	   which	   is	   also	   a	   common	  
characteristic	  seen	  in	  other	  verified	  cis-­‐regulatory	  RNA	  elements	  for	  ribosomal	  proteins	  (Zengel	  
et	  al.,	  1994).	  	  
	  
The	   RNA	  we	   have	   characterized	   from	  B.	   subtilis	   joins	   the	   collection	   of	   RNA	   structures	   that	   is	  
widely	  distributed	  and	  universally	   interact	  with	   ribosomal	  proteins	   (L1,	  L10,	  and	  S2)	   (Fu	  et	  al.,	  
2013).	  If	  its	  regulatory	  roles	  are	  confirmed	  by	  future	  study,	  this	  RNA	  would	  also	  fill	  a	  current	  gap	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In	  this	  chapter,	  we	  constructed	  a	  lacZ	  reporter	  system	  in	  S.	  pombe	  and	  a	  dual-­‐luciferase	  reporter	  
system	   in	   E.	   coli.	   Both	   systems	   were	   designed	   to	   carry	   out	   in	   vivo	   characterization	   of	   RNA-­‐
protein	   interactions	   and	   serve	   as	   potential	   platforms	   for	   high	   throughput	   screening	   of	   RNA-­‐
binding	  small	  molecules.	  
	  
lacZ	  reporter	  system	  in	  Schizosaccharomyces	  pombe	  
System	  design	  
An	   S.	   pombe-­‐based	   reporter	   system	   was	   designed	   to	   detect	   biological	   compounds	   or	   small	  
molecules	  that	  selectively	  interact	  with	  bacterial	  ribosomal	  protein	  cis-­‐regulatory	  RNA	  elements.	  
The	  system	  consists	  of	  two	  plasmids:	  pNMT41	  (a	  gift	  from	  Dr.	  Hoffman)	  carries	  the	  genes	  coding	  
for	  bacterial	  ribosomal	  proteins	  following	  a	  thiamine	  repressible	  promoter	  nmt1;	  pCHY24	  (a	  gift	  
from	  Dr.	  Hoffman)	  carries	   the	  cis-­‐regulatory	  RNA-­‐lacZ	   translational	   fusion	  that	   is	  controlled	  by	  
the	  glucose	  repressible	   fbp1	  promoter	   (Hoffman	  et	  al.,	  1989).	  By	  expressing	  ribosomal	  protein	  
and	   the	   RNA-­‐lacZ	   fusion	   simultaneously,	   the	   expression	   of	   β-­‐galactosidase,	   encoded	   by	   lacZ	  
gene,	   could	   reflect	   the	  RNA-­‐protein	   interaction.	  When	  protein	  and	  RNA	  bind,	   low	  Miller	  units	  
would	   be	   observed	   in	  Miller	   assays,	   whereas	   high	  Miller	   units	   indicate	   a	   lack	   of	   RNA-­‐protein	  
interaction.	  	  
	  
β-­‐galactosidase	  assay	  results	  
We	  tested	  three	  ribosomal	  protein-­‐RNA	  pairs,	  E.	  coli	  S15,	  G.	  kaustophilus	  S15,	  and	  B.	  subtilis	  S4.	  
For	  E.	  coli	  S15,	  lacZ	  expression	  was	  inducible,	  however	  no	  consistent	  difference	  was	  observed	  in	  
β-­‐galactosidase	  level	  when	  S15	  protein	  overexpression	  was	  induced	  (Figure	  14),	  suggesting	  that	  
either	   the	   protein	   overexpression	   was	   not	   successful	   in	   S.	   pombe	   or	   there	   was	   not	   enough	  
protein	  expression	  to	  saturate	  the	  RNA	  motif	  and	  change	  lacZ	  expression.	  For	  the	  latter	  two,	  we	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could	  not	   induce	   lacZ	  expression	  at	  all.	  Considering	  the	  fact	  that	  the	  G.	  kaustophilus	  S15	  RNA-­‐
lacZ	  fusion	  is	  functional	  in	  E.	  coli	  when	  expressing	  from	  a	  bacterial	  plasmid	  with	  an	  L-­‐arabinose-­‐
inducible	   promoter	   (Betty	   Dixon,	   unpublished	   data),	   and	   that	   the	   S4	   RNA-­‐lacZ	   fusion	   was	  
functional	   in	  B.	   subtilis	  with	   various	  promoters	   (Grundy	  et	   al.,	   1991),	  we	   speculate	   that	   these	  
two	  bacterial	  RNA	  structures	  may	  not	  be	  compatible	  with	  the	  transcription/translation	  system	  in	  
S.	   pombe.	   Thus,	   the	   same	   motif	   that	   allows	   transcription/translation	   in	   the	   absence	   of	   its	  
protein	  partner	  in	  bacteria	  may	  block	  transcription/translation	  in	  yeast.	  
	  
Discussion	  
In	  this	  work,	  we	  incorporate	  three	  ribosomal	  proteins	  and	  their	  known	  partner	  RNA	  motifs	  into	  
the	  lacZ	  reporter	  system	  designed	  in	  S.	  pombe,	  as	  the	  proof-­‐of-­‐concept	  test.	  	  We	  can	  only	  collect	  
readable	  data	  with	  the	  E.	  coli	  S15-­‐RNA	  pair,	  however,	  our	  inconsistent	  results	  suggest	  no	  specific	  
RNA-­‐protein	  interaction.	  In	  previous	  studies,	  the	  RNA-­‐mediated	  E.	  coli	  S15	  regulation	  has	  been	  
extensively	   studied	  and	  validated	  both	   in	   vitro	   and	   in	   vivo	   using	  E.	   coli-­‐based	   reporter	   system	  
(Philippe	  et	  al.,	  1990;	  Scott	  et	  al.,	  2001).	  One	  explanation	  for	  the	  inconsistent	  results	  we	  observe	  
is	   that	   our	  S.	   pombe-­‐based	   system	  may	   need	   further	   tuning.	   It	   is	   also	   highly	   likely	   that	   these	  
bacterial	  RNA	  motifs	  are	  not	  compatible	  with	  eukaryotic	  environment,	  considering	  the	  fact	  that	  
we	  cannot	  turn	  on	  the	  expression	  of	  lacZ	  gene	  with	  G.	  kaustophilus	  S15-­‐bindng	  RNA	  motif	  or	  B.	  
subtilis	   S4-­‐binding	   RNA	   motif	   attached	   to	   its	   5’	   end	   in	   the	   S.	   pombe	   system,	   although	   both	  
motifs	  have	  been	  successfully	  validated	  in	  bacterial	  reporter	  systems	  (Betty	  Dixon,	  unpublished	  
data)	  (Grundy	  et	  al.,	  1991).	  In	  general,	  we	  speculate	  that	  the	  S.	  pombe	  transcription/translation	  
system	   is	   acting	   on	   the	   bacterial	   RNA	   motifs	   through	   some	   unexpected	   mechanisms.	   More	  
literature	   search	   as	   well	   as	   experimental	   research	   need	   to	   be	   done	   before	   we	   consider	   this	  
yeast-­‐based	  reporter	  system	  feasible.	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Dual	  luciferase	  reporter	  system	  in	  E.	  coli	  
System	  design	  
To	  assess	  RNA-­‐protein	   interaction	   in	  vivo,	  we	  designed	  a	  dual-­‐luciferase	   reporter	   system	   in	  E.	  
coli.	  This	  system	  consists	  of	  two	  plasmids:	  a	  petHT	  plasmid	  for	  protein	  expression	  and	  a	  pBAD33	  
derivative	   plasmid	   (Figure	   15)	   carrying	   two	   reporter	   genes,	   coding	   for	   firefly	   and	   renilla	  
luciferase.	   The	   wildtype	   RNA	   sequence	   to	   be	   tested,	   including	   the	   native	   Shine-­‐Dalgarno	  
sequence	   could	   be	   fused	   to	   one	   luciferase	   gene	   through	   translational	   fusion,	   and	   the	  mutant	  
RNA	  could	  be	  fused	  to	  the	  other	  luciferase	  gene.	  Each	  RNA-­‐luciferase	  translational	  fusion	  has	  its	  
own	  L-­‐arabinose-­‐inducible	  promoter	  and	  a	  terminator.	  Since	  Firefly	  and	  Renilla	  luciferases	  react	  
with	   specific	   substrates	   (firefly	   luciferin	   and	   renilla	   luciferin,	   respectively),	   such	   design	  would	  
allow	   us	   to	   measure	   two	   different	   RNA-­‐protein/peptide	   interactions	   in	   the	   same	   system	  
simultaneously	   (Grentzmann	   et	   al.,	   1998;	   Harger	   et	   al.,	   2003;	  Mcnabb	   et	   al.,	   2005).	  When	   a	  
protein	   interacts	  specifically	  with	   the	  wildtype	  RNA	  target,	  a	  change	   in	   the	  expression	   level	  of	  
the	   corresponding	   fusion	   luciferase	   is	   expected,	   whereas	   the	   expression	   level	   of	   the	   mutant	  
RNA-­‐fused	  luciferase	  is	  expected	  to	  stay	  the	  same.	  In	  addition,	  both	  E.	  coli	  culture	  and	  luciferase	  
color	  assays	  can	  be	  performed	  using	  multi-­‐well	  plates,	  providing	  a	  potential	  platform	  for	  high-­‐
throughput	  screening	  for	  RNA-­‐binding	  biological	  compounds	  and	  small	  molecules.	  	  
	  
Preliminary	  results	  suggest	  no	  L1	  protein-­‐RNA	  interaction	  in	  vivo	  
We	  tested	  two	  RNA	  structures,	  the	  structured	  RNA	  preceding	  rplA	  from	  G.	  kaustophilus	  (64	  nt)	  
and	  the	  one	  preceding	  rplA	  from	  E.	  coli	  (93	  nt,	  including	  the	  native	  transcription	  initiation	  site).	  
Both	  RNAs	  are	  known	  to	  interact	  with	  L1	  ribosomal	  protein	   in	  vitro	   (Fu	  et	  al.,	  2013).	  However,	  
our	   in	   vivo	   experiment	   results	   do	   not	   support	   the	   RNA-­‐protein	   interaction	   and	   the	   RNA-­‐
mediated	   regulation	   (Figure	   16).	   In	   both	   constructs	   we	   fused	   the	   wildtype	   RNA	   to	   renilla	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luciferase	  gene.	  Considering	  that	  renilla	  luciferase	  color	  assays	  generally	  yielded	  higher	  readouts	  
than	  those	  of	  firefly	  luciferase	  in	  our	  pilot	  experiments,	  such	  design	  would	  be	  helpful	  to	  reflect	  
even	   small	   changes	   associated	   with	   the	   wildtype	   RNA-­‐protein	   interaction.	   In	   general,	   we	  
observed	   relatively	   stable	   firefly	   luciferase	   activity	   after	   30-­‐60	   min’s	   overexpression	   of	   G.	  
kaustophilus	  L1	  protein	  in	  E.	  coli,	  and	  varied	  and	  unexpected	  changes	  of	  renilla	   luciferase	  level	  
under	  the	  same	  condition.	  One	  possibility	   is	  that	  not	  enough	  L1	  protein	  were	  expressed	  in	  the	  
system	  to	   interact	  with	   the	  RNA	  and	   induce	  changes	   in	   luciferase	  expression.	  However,	  as	  we	  
demonstrated	  in	  other	  experiments	  that	  unbalanced	  ribosomal	  protein	  level	  and	  ribosomal	  RNA	  
level	  lead	  to	  ill	  growth	  of	  	  E.	  coli	  (Figure	  19),	  we	  also	  observed	  significant	  cell	  density	  (OD)	  drop	  
and	   firefly	   luciferase	   expression	   drop	   after	   overexpressing	   L1	   protein	   in	   E.	   coli	   over	   1	   hour.	  
Considering	  our	  inconclusive	  assay	  data,	  the	  culturing	  condition	  may	  need	  further	  optimization.	  
The	  difficulty	  of	  engineering	  L1	  overpression	  strain	  might	  also	  be	  the	  reason	  why	  RNA-­‐mediated	  
L1	   regulation	   has	   only	   been	   proved	   using	   in	   vitro	   cell-­‐free	   transcription-­‐translation	   system	  
(Hanner	  et	  al.,	  1994).	  	  
	  
Discussion	  
Dual-­‐luciferase	  reporter	  system	  in	  E.	  coli	  
We	   do	   not	   observe	   consistent	   results	   suggesting	   specific	   G.	   kaustophilus	   L1	   RNA-­‐protein	  
interaction	  using	  the	  dual	  luciferase	  reporter	  system	  constructed	  in	  E.	  coli.	  It	  might	  suggest	  that	  
the	   system	  need	   to	  be	   further	   fine-­‐tuned	   to	   report	   the	  RNA-­‐mediated	   regulation.	   In	  addition,	  
previous	   literatures	   show	   that	   the	   RNA-­‐mediated	   L1	   regulation,	   besides	   the	   native	   E.	   coli	   L1	  
regulation	   system	   (Thomas	   &	   Nomura,	   1987),	   is	   hardly	   investigated	   using	   in	   vivo	   reporter	  
systems	   in	   E.	   coli.	   For	   example,	   the	   regulation	   of	   L1	   operon	   in	  Methanococcus	   Vannielii,	  M.	  
thermolithotrophicus,	   and	   M.	   jannaschii	   are	   characterized	   using	   cell-­‐free	   in	   vitro	   systems	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(Hanner	  et	  al.,	  1994;	  Kraft	  et	  al.,	  1999).	  This	  difficulty	  might	  result	  from	  the	  conservation	  of	  the	  
L1-­‐binding	  RNA	  motif,	  as	  well	  as	  the	  L1	  protein	  across	  bacteria	  (Fu	  et	  al.,	  2013),	  and	  may	  imply	  
the	  limitation	  of	  applying	  E.	  coli	  to	  L1	  related	  studies.	  Thus,	  to	  test	  the	  feasibility	  of	  this	  E.	  coli-­‐
based	  dual	  luciferase	  reporter	  system,	  we	  could	  incorporate	  other	  known	  ribosomal	  protein	  and	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Phage	  display	  for	  selecting	  RNA-­‐binding	  small	  peptides	  
In	   this	  chapter,	  we	  aimed	  to	  use	  the	  phage	  display	  technique	  to	  select	   for	  small	  peptides	  that	  
can	   simulate	   the	   native	   interaction	   between	   the	   regulatory	   RNA	   and	   its	   ribosomal	   protein	  
binding	   partner.	   Previously,	   phage	   display	   technology	   has	   been	   used	   extensively	   in	   vitro	   to	  
identify	  peptides,	  proteins,	  and	  antibodies	  based	  on	  specific	  interaction	  or	  catalytic	  activity	  with	  
a	   given	   target	   (Parmley	   et	   al.,	   1988;	   Sidhu,	   2000;	   Smith,	   1985).	   Phage	   display	   describes	   a	  
selection	  technique	  in	  which	  a	  peptide	  library	  is	  expressed	  together	  with	  the	  capsid	  protein	  of	  a	  
phage	  virion,	  while	  the	  gene	  coding	  for	  each	  variant	  is	  located	  on	  the	  inside	  (Rodi	  &	  Makowski,	  
1999).	  Viruses	  displaying	  peptides	  bind	  specifically	  to	  immobilized	  targets	  and	  can	  be	  separated	  
from	  phage	  library	  pool	  by	  panning,	  with	  the	  unbound	  phage	  being	  washed	  away.	  Phage	  display	  
has	  been	  experimentally	  proven	  to	  be	  feasible	  for	  targeting	  proteins	  (Biorn	  et	  al.,	  2004),	  protein-­‐
binding	  DNAs	  (Cheng	  et	  al.,	  1996),	  or	  protein-­‐binding	  RNAs	  (Danner	  et	  al.,	  2001;	  Li	  et	  al.,	  2009;	  
Llano-­‐Sotelo	  et	  al.,	  2009).	  The	  Ph.D.TM	  Phage	  Display	  system	  from	  NEB	  is	  based	  on	  a	  M13	  phage	  
vector,	  modified	  for	  displaying	  peptide	  libraries	  as	  N-­‐terminal	  fusions	  to	  the	  minor	  coat	  protein	  
pIII	  (Cwirla	  et	  al.,	  1990;	  Devlin	  et	  al.,	  1990;	  Scott	  et	  al.,	  1990).	  pIII	  modulates	  phage	  infection	  by	  
binding	  to	  the	  F-­‐pilus	  of	   the	  host	  cell,	  and	   is	  present	  as	  a	   five	  copy	  cluster	  at	  one	  end	  of	  M13	  
virion	  (Rodi	  et	  al.,	  1999).	  Fusing	  a	  peptide	  with	  no	  more	  than	  50	  residues	  to	  pIII	  does	  not	  affect	  
its	  infectivity	  function.	  All	  of	  the	  commercially	  available	  libraries	  from	  NEB	  have	  complexities	  on	  
the	  order	  of	  109	   independent	  clones,	  which	   is	  sufficient	   to	  encode	  most	  of	   the	  possible	  7-­‐mer	  
(1.28	  x	  109)	  peptide	  sequences.	  The	  large	  number	  of	  clones	  is	  also	  the	  main	  advantage	  of	  phage	  
display	   library	   compared	   with	   other	   libraries	   with	   typical	   	   	   ̴104	   clones	   (i.e.	   cDNA	   libraries	  
expressed	  in	  phage	  lambda).	  Theoretically,	  such	  in	  vitro	  system	  could	  be	  used	  for	  selecting	  small	  




RNA	  target	  design	  
A	  62-­‐nt	  RNA	  (same	  as	  that	  in	  filter-­‐binding	  assays)	  and	  a	  81-­‐nt	  RNA	  (longer	  at	  the	  5’	  end),	  
containing	  the	  L1-­‐binding	  site	  and	  RBS	  that	  precede	  gene	  rplK,	  was	  in	  vitro	  transcribed	  from	  G.	  
kaustophilus	  genome.	  The	  last	  17	  nucleotides	  at	  the	  3’	  end	  was	  hybridized	  to	  a	  biotin-­‐labeled	  
DNA	  primer	  (Figure	  17)	  (Li	  et	  al.,	  2009).	  Both	  RNA	  target	  sequences	  cover	  the	  minimal	  
requirement	  for	  forming	  the	  L1	  protein-­‐binding	  structure	  and	  can	  be	  isolated	  by	  magnetic	  beads	  
through	  biotin-­‐streptavidin	  binding.	  To	  increase	  RNA-­‐protein	  interaction	  specificity,	  we	  also	  
constructed	  a	  mutant	  version	  of	  the	  62-­‐nt	  RNA	  target	  without	  the	  biotin	  tail	  by	  introducing	  the	  
same	  two	  G-­‐to-­‐A	  mutations	  as	  we	  did	  for	  filter-­‐binding	  assays	  (Figure	  6).	  	  
	  
RNA-­‐binding	  heptapeptide	  selection	  	  
The	   selection	   for	   RNA-­‐binding	   heptapeptides	   was	   designed	   to	   include	   4	   rounds.	   Round	   1	  
through	   3	  were	   positive	   selections	  where	   the	  wildtype	  RNA	   is	   used	   as	   the	   target,	  whereas	   in	  
Round	  4	  a	  counter	  selection	  was	  carried	  out	  in	  the	  presence	  of	  the	  mutant	  target.	  By	  using	  this	  
approach,	   we	   aimed	   to	   eliminate	   all	   the	   non-­‐specific	   peptide	   binders	   and	   save	   peptides	   that	  
interact	   with	   the	   RNA	   structure	   at	   the	   same	   site	   as	   L1	   protein	   does.	   In	   addition,	   we	   also	  
employed	   two	   elution	  methods,	   specific	   and	   low-­‐pH,	   to	   isolate	   RNA-­‐bound	   phage	   after	   each	  
round	   of	   selection,	   as	   suggested	   in	   manufacture’s	   protocol.	   The	   specific	   elution	   relies	   on	  
excessive	   nonbiotinylated	   elution	   RNAs	   to	   compete	   the	   RNA-­‐bound	   phage	   off	   the	   beads,	  
whereas	   the	   low-­‐pH	   elution	   releases	   the	   RNA-­‐bound	   phage	   from	   the	   beads	   by	   using	   acidic	  
buffer	  to	  break	  the	  biotin-­‐streptavidin	  bound.	  	  
	  
With	  the	  62-­‐nt	  RNA	  target,	  	  the	  “winner”	  peptides	  was	  FSGGGNH	  (10/10,	  low-­‐pH	  elution;	  8/10,	  
specific	  elution	  (Table	  2).	  The	  other	  two	  were	  NYSYIPP	  and	  TVNFKLY).	  With	  the	  81-­‐nt	  RNA	  target,	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the	   “winner”	   peptides	   were	   QMLLRLP	   (QMLLRLP,	   low-­‐pH	   elution),	   	   NPTRKPK	   (2/9,	   low-­‐pH	  
elution),	  MPTRPNK	   (3/9,	   specific	   elution),	   and	  MITTTRK	   (2/9,	   specific	   elution)	   (Table	   2).	   All	   of	  
these	   selected	   peptides	   are	   positively	   charged	   which	   is	   a	   characteristic	   commonly	   seen	   in	  
RNA/DNA	  binding	  peptides	  due	   to	   the	  negatively	   charged	  phosphate	  backbone.	  Normally,	   the	  
low-­‐pH	  elution	  method	  generates	  a	  wider	  variety	  of	  sequences	  due	  to	  the	  strong	  cleavage	  of	  the	  
biotin-­‐streptavidin	  bond.	  However,	  such	  results	  were	  not	  seen	  in	  our	  experiments.	  
	  
Growth	  curve	  assays	  
To	   examine	   how	   select	   peptides	   affect	   bacteria	   growth,	  we	   introduced	   6	   of	   them	   into	  E.	   coli	  
BL21	   strain.	  We	  overexpressed	   FSGGGNH,	   FSGGGNHGGGS,	   TVNFKLY,	   TVNFKLYGGGS,	  NYSYIPP,	  
and	  NYSYIPPGGGS	  in	  E.	  coli	  cells	  and	  monitored	  E.	  coli	  growth	  by	  measuring	  the	  cell	  density	  over	  
a	  period	  of	   time	   (Figure	  18).	  The	  GGGS	  sequence	  acts	  as	   the	  C-­‐terminal	   spacer	  between	  each	  
displayed	  peptide	  and	  the	  M13	  phage	  virion	  in	  the	  Ph.D.	  system	  (NEB).	  We	  included	  the	  spacer-­‐
attaching	  peptides	   in	   this	  experiment	  as	  well	   since	  such	  spacer	  might	  be	   involved	   in	   the	  RNA-­‐
peptide	   interaction	   during	   the	   selection.	   Our	   data	   show	   that	   the	   overexpression	   of	   TVNFKLY	  
leads	  to	  significant	  cell	  death	  compared	  to	  that	  of	  the	  control	  group	  (empty	  pET-­‐HT),	  whereas	  
the	  overexpression	  of	  the	  other	  five	  peptides	  does	  not	  make	  notable	  differences	  in	  cell	  growth	  
under	   the	   same	   growth	   condition.	   To	   exclude	   the	   possibility	   that	   TVNFKLY	   overexpression-­‐
associated	   growth	   defect	  was	   due	   to	   the	   accumulation	   of	   insoluble	   small	   peptides,	   a	   peptide	  
with	   reversed	  animo	  acid	   sequence	   (YLKFNVT)	  was	  also	   tested	  using	   the	  same	  overexpression	  
system.	  To	  our	  surprise,	  normal	  cell	  growth	  was	  observed,	  suggesting	  that	  the	   insolubility	  was	  




In	  addition,	   to	  demonstrate	   that	   the	  balance	  between	  the	   level	  of	   ribosomal	  proteins	  and	  the	  
level	   of	   ribosomal	   RNAs	   is	   important	   for	   healthy	   bacterial	   growth,	   we	   also	   overexpressed	  G.	  
kaustophilus	   ribosomal	   protein	   L1,	   S6,	   S18,	   and	   S15	   using	   the	   same	   method	   in	   E.	   coli	   BL21	  
(Figure	  19).	  For	  example,	  we	  speculated	  that	  overexpressed	  L1	  would	  bind	  to	  the	  RNA	  element	  
on	   L1	   operon	   and	   inhibit	   expression	   of	   both	   native	   L1	   and	   L11.	   Thus,	   the	   accumulation	   of	  G.	  
kaustophilus	   L1	   and	   the	   deficiency	   of	   native	   E.	   coli	   L11	   would	   lead	   to	   E.	   coli	   cell	   death.	  
Interestingly,	   all	   of	   these	   ribosomal	   proteins	   caused	   defective	   bacterial	   growth	   when	  
overexpressed.	  L1	  overexpression	  led	  to	  significant	  cell	  death	  in	  a	  way	  very	  similar	  to	  that	  of	  the	  
peptide	  TVNFKLY	  overexpression.	  S18	  and	  S6	  overexpression	  also	  resulted	   in	  notable	  bacterial	  
death	   but	   not	   as	   fatal	   as	   that	   observed	   for	   L1.	   Defective	   growth	   seen	   with	   the	   S15	  
overexpression	  was	  not	  quite	  expected	  since	  G.	  kaustophilus	  S15	  does	  not	  interaction	  with	  the	  
S15	  RNA	  element	  from	  E.	  coli	   in	  vivo	   (Betty	  Dixon,	  unpublished	  data),	  and	  the	  gene	  coding	  for	  
S15,	   rpsO,	   is	   the	  only	  gene	  on	   the	  S15	  operon	   in	  E.	   coli.	  However,	   it	   could	  also	  be	   interacting	  
with	   the	  E.	   coli	   ribosome.	   In	  general,	   the	  growth	  curve	  data	   reveal	   the	  negative	  effect	  of	  one	  
selected	  peptide	  on	  E.	  coli,	  however,	  without	  further	  in	  vivo	  and	  in	  vitro	  experiments,	  we	  could	  
not	  conclude	  that	  the	  defective	  growth	  seen	  with	  TVNFKLY	  overexpression	  was	  caused	  by	  direct	  
peptide-­‐RNA	  interaction.	  	  
	  
Discussion	  	  
In	  this	  work,	  we	  carry	  out	  phage	  display	  selections	  using	  the	  L1-­‐binding	  RNA	  as	  the	  target.	  We	  
use	  both	  specific	  and	  low-­‐pH	  elution	  methods	  during	  selection	  Round	  2-­‐4	  and	  observe	  variations	  
in	   output	   peptides.	   Theoretically,	   the	   low-­‐pH	   elution	   method	   provides	   more	   diverse	   output,	  
since	  it	  releases	  the	  RNA-­‐bound	  phage	  by	  releasing	  the	  RNA	  target	  off	  the	  beads,	  whereas	  the	  
specific	  elution	  competes	  the	  bound	  phage	  off	  the	  beads	  by	  increasing	  the	  concentration	  of	  free	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RNA	  targets	  in	  solution,	  where	  strong	  binders	  may	  still	  be	  on-­‐bead	  (Li	  et	  al.,	  2009).	  However,	  we	  
see	  more	  diverse	  output	  with	  the	  specific	  elution	  method,	  which	  could	  be	  due	  to	  the	  small	  size	  
of	  sequenced	  samples	  (10	  for	  each	  elution	  method)	  or	  that	  some	  RNA-­‐binding	  phage	  were	  killed	  
by	  low	  pH	  buffer	  before	  neutralization.	  	  
	  
We	  show	  with	  in	  vivo	  assays	  that	  the	  overexpression	  of	  one	  particular	  peptides,	  TVNFKLY,	  in	  E.	  
coli	   leads	   to	   severe	   growth	   defect.	   Without	   in	   vitro	   data	   we	   cannot	   yet	   conclude	   that	   this	  
observation	   is	   directly	   linked	   to	   L1	   RNA-­‐peptide	   interaction.	  However,	  we	   see	   normal	   growth	  
when	  overexpressing	   the	   same	  peptide	  with	   reversed	   amino	   acid	   sequence	   (YLKFNVT),	  which	  
lowers	   the	   possibility	   that	   the	   abnormality	   in	   E.	   coli	   growth	   is	   caused	   by	   accumulation	   of	  
insoluble	  peptides.	  	  
	  
One	  potential	  problem	  with	  phage	  display	  selection	  is	  that	  the	  most	  strong	  RNA-­‐binders	  may	  kill	  
E.	   coli	   during	   amplification	   step	   by	   disrupting	   the	   native	   ribosomal	   protein	   regulation	   system	  
and	  never	  get	  selected	  out.	  However,	  considering	  our	  specific	  aim,	  which	   is	   to	  select	   for	  small	  
peptides	  that	  could	  target	  at	  a	  specific	  RNA	  motif	  and	  act	  as	  potential	  antibacterial	  leads,	  such	  










Materials	  and	  Methods	  
Chapter	  2	  
5’	  RACE	  	  
5’	   RACE	   was	   performed	   with	   the	   Invitrogen	   GeneRacer	   kit	   on	   the	   total	   RNA	   extracted	   from	  
Bacillus	  subtilis	   log	  phase	  culture	  to	   identify	   the	  5’	  end	  transcription	   initiation	  site.	  All	  primers	  
were	   listed	   in	   Table	  1.	   First	   strands	  were	   synthesized	  using	   two	  gene-­‐specific	  primers	  derived	  
from	  rplK	  and	  rplA	  coding	  regions	  respectively.	  RACE	  PCR	  was	  done	  using	  the	  two	  first	  strands	  as	  
templates,	  a	   linker-­‐specific	  primer	  and	  a	  second	  set	  of	  gene-­‐specific	  primers.	  All	  PCR	  products	  
were	  cloned	  into	  TOPO	  vectors	  (Invitrogen	  TOPO-­‐cloning	  kit)	  and	  sequenced.	  	  
	  
Filter-­‐binding	  assays	  
The	  two	  predicted	  RNA	  structure	  sequences	  (preceding	  rplA:	  37	  nt,	  preceding	  rplK:	  41	  nt,	  both	  
including	   the	   T7	   promoter	   sequence)	  were	   generated	   from	  Geobacillus	   kaustophilus	   genomic	  
DNA	  by	  PCR,	  transcribed	  in	  vitro	  with	  T7	  RNA	  polymerase,	  and	  5’-­‐labeled	  with	  [γ-­‐32P]	  ATP	  in	  the	  
presence	   of	   T4	   PNK.	  Mutants	   of	   these	   RNAs	   (including	   two	  G-­‐to-­‐A	  mutations)	  were	   prepared	  
with	  the	  same	  methods.	  G.	  kaustophilus	  ribosomal	  protein	  L1	  was	  over-­‐expressed	  from	  pET-­‐HT	  
vector	   in	   E.	   coli	   BL21	   (Block,	   Puerta-­‐Fernandez,	  Wallace,	   &	   Breaker,	   2011)	   and	   purified	   using	  
denaturing	   ion-­‐exchange	   chromatography.	   Filter-­‐binding	   assays	  were	   conducted	   as	   previously	  
described	  (Köhrer	  et	  al.,	  1998).	  A	  fixed	  amount	  of	  RNA	  (approx.	  1	  nM,	  500	  cpm)	  was	  incubated	  
with	  L1	  protein	  in	  serial	  dilutions	  (0	  –	  500	  nM)	  in	  a	  total	  volume	  of	  50	  μL	  for	  15	  min	  at	  42	  °C	  (L1	  
binding	   buffer:	   50mM	   Tris–HCl	   pH	   7.6	   at	   25_C,	   20mM	   MgCl2,	   500mM	   KCl,	   1mM	   beta-­‐
mercaptoethanol,	   0.04%	  BSA).	   The	   RNA-­‐protein	   complexes	  were	   captured	   by	   vacuum	   suction	  
through	   a	   nitrocellulose	   membrane	   (Optitran	   BA	   S-­‐85	   reinforced	   nitrocellulose,	   Whatman),	  
whereas	  the	  unbound	  RNAs	  were	  retained	  on	  a	  nylon	  membrane	  (N+	  hybond,	  GE	  Healthcare).	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Both	  membranes	  were	  washed	  once	  with	  50	  μL	  binding	  buffer.	  The	  radioactivity	  was	  quantified	  
using	  a	  GE	  Healthcare	  STORM	  820	  phosphoimager	  and	   ImageQuant.	   	  The	  protein-­‐binding	  RNA	  
fraction	  	  is	  calculated	  as	  (counts	  on	  the	  nitrocellulose	  membrane)/(counts	  on	  both	  membranes).	  	  
	  
Chapter	  3	  
5’	  and	  3’	  RACE	  
5’	  and	  3’	  RACE	  were	  both	  performed	  with	  the	  Invitrogen	  GeneRacer	  kit	  on	  Bacillus	  subtilis	  total	  
RNA	   extracted	   from	   a	   log	   phase	   culture	   to	   identify	   the	   transcription	   initiation	   site,	   the	  
termination	  site,	  and	  the	  transcriptional	  organization	  of	  the	  S6	  operon.	  All	  primers	  were	  listed	  in	  
Table	  1.	   In	  5’	  RACE,	   first	   strands	  were	   synthesized	  with	  a	   set	  of	   gene-­‐specific	  primers	  derived	  
from	   rpsF	   and	   rpsR	   respectively.	   RACE	   PCR	   was	   done	   using	   the	   first	   strands	   as	   templates,	   a	  
linker-­‐specific	  primer	  and	  a	  second	  set	  of	  gene-­‐specific	  primers,	  and	  products	  were	  cloned	  into	  
TOPO	   vectors	   (Invitrogen	   TOPO-­‐cloning	   kit)	   for	   sequencing.	   3’	   RACE	   was	   conducted	   by	  
adenylation	  of	   the	   total	  RNA	  extract	   followed	  by	   reverse	   transcription	  with	  a	  dT	  primer.	  RACE	  
PCR	   was	   done	   using	   the	   reverse	   transcript	   as	   the	   template,	   a	   gene-­‐specific	   primer,	   and	   an	  
Anchor	  primer,	  and	  products	  were	  cloned	   into	  TOPO	  vectors	   (Invitrogen	  TOPO-­‐cloning	  kit)	   for	  
sequencing.	  
	  
RNA	  and	  protein	  preparation	  
The	   sequence	  preceding	   rpsF	  was	  PCR	  amplified	   from	  Bacillus	   subtilis	   genomic	  DNA	  with	  a	  T7	  
promoter	  and	  was	  in	  vitro	  transcribed	  with	  T7	  RNA	  polymerase	  to	  generate	  the	  rpsF_5-­‐69	  RNA	  
and	  rpsF_1-­‐69	  RNA.	  Purified	  RNA	  was	  5’-­‐labeled	  with	  [γ-­‐32P]	  ATP	  in	  the	  presence	  of	  T4	  PNK.	  To	  
produce	   RNA	   mutants	   (65	   nt,	   M1-­‐M6),	   DNA	   templates	   carrying	   mutations	   were	   generated	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through	  QuickChange	  mutagenesis	   as	   the	   first	   step,	   followed	  by	   the	   same	  methods	  described	  
above.	  
Genes	  coding	  for	  Geobacillus	  subtilis	  were	  cloned	  in	  to	  pET-­‐HT	  and	  transformed	  into	  E.	  coli	  BL21.	  
S6	   and	   S18	   proteins	   were	   overepressed	   from	   the	   T7	   promoter	   and	   purified	   similarly	   to	   that	  
previously	  described	  (Culver	  et	  al.,	  1999).	  Cells	  were	  lysed	  in	  Buffer	  E	  (20	  mM	  HEPES	  [pH	  7.6],	  20	  
mM	  KCl,	  and	  6	  mM	  BME).	  S6	  was	  purified	  with	  Buffer	  C	  (20	  mM	  NaOAc	  [pH	  5.0],	  20	  mM	  KCl,	  and	  
6	  mM	  BME)	  by	  nondenaturing	  FPLC	  cation	  exchange.	  S18	  was	   insoluble	  and	  was	  purified	  from	  
inclusion	  bodies	  using	  Buffer	  B	  (20	  mM	  Tris-­‐HCl	  [pH	  7.6],	  20	  mM	  KCl,	  6	  M	  urea,	  and	  6	  mM	  BME)	  
by	  denaturing	  chromatography.	  Purified	  proteins	  were	  dialyzed	  against	  Buffer	  D	  (S18	  with	  4	  M	  
urea)	  and	  stored	  at	  4	  °C.	  
	  
Electrophoretic	  mobility	  shift	  assays	  (EMSA)	  
EMSA	  assays	  were	  performed	  to	  study	  the	  RNA-­‐protein	  interaction	  related	  to	  the	  S6	  operon.	  A	  
fixed	  amount	  of	  RNA	  (rpsF_5-­‐69,	  approx.	  1	  nM,	  1000	  cpm)	  was	  incubated	  with	  proteins	  (S6,	  S18,	  
and	   S6:S18	   [1:1])	   in	   serial	   dilutions	   (0	   –	   500	   or	   600	   nM)	   in	   a	   total	   volume	   of	   10	   μL	   at	   25	   °C	  
(binding	  buffer:	  50	  mM	  Tris-­‐HCl	  [pH	  7.6],	  20	  mM	  MgCl2,	  150	  mM	  KCl,	  1	  mM	  BME,	  0.04%	  BSA).	  
After	   30	   min’s	   incubation,	   5	   μL	   50%	   glycerol	   was	   added	   before	   loading	   onto	   a	   native	   10%	  
acrylamide	  gel	  which	  had	  been	  prerun	  for	  60	  min	  at	  160	  V	  under	  25	  °C.	  The	  loaded	  gel	  was	  run	  
at	   350	  V	   at	   4	   °C	   and	  dried	   and	   imaged	  using	  GE	  Healthcare	   STORM	  820	  phosphorimager	   and	  
radioactivity	   quantified	   using	   ImageQuant.	   Quantifications	   were	   fit	   to	   a	   standard	   curve	  
generated	   by	   (Fmax	   *	   yn)	   /	   (xn	  +	   KDn	   ),	   where	   Fmax	   is	   the	  maximum	   fraction	   bound,	   y	   is	   the	  




For	   individual	  protein	  titrations,	  600	  nM	  S6	  was	   incubated	  with	  S18	   in	  serial	  dilutions	   (0	  nM	  –	  
600	  nM)	   in	  binding	  buffer	  for	  10	  min	  before	  a	  fixed	  amount	  of	  RNA	  (rpsF_5-­‐69,	  approx.	  1	  nM,	  
1000	   cpm)	   was	   added.	   The	   reactions	   were	   further	   incubated	   for	   20	   min.	   The	   RNA-­‐protein	  
mixture	  was	  examined	  by	  EMSA	  as	  described	  above.	  For	   the	  S18-­‐concentration-­‐fixed	  titration,	  
500	   nM	   was	   held	   as	   the	   maximum	   concentration,	   since	   S18	   at	   600	   nM	   displayed	   significant	  
aggregation	  and	  uninterruptable	  EMSA	  results.	  	  	  	  
	  
Nuclease	  protection	  assays	  
Nuclease	  protection	  assays	  were	  conducted	  to	  investigate	  the	  secondary	  structure	  of	  the	  bound	  
and	  unbound	  RNAs.	  The	  RNA-­‐protein	  binding	  reactions	   in	  these	  assays	  were	   identical	  to	  those	  
used	  for	  EMSA.	  After	  incubation,	  each	  reaction	  was	  treated	  with	  RNase	  A	  (Ambion,	  20	  pg)	  and	  
RNase	  V1	  (Ambion,	  0.002	  units)	  for	  10	  and	  5	  min	  at	  25	  °C,	  respectively	  followed	  by	  inactivation	  
of	   the	   nuclease.	   Processed	   RNA	   fragments	   were	   isolated	   by	   ethanol	   precipitation	   and	   were	  
resuspended	  in	  10	  μL	  water	  and	  10	  μL	  urea	  loading	  solution	  (10	  M	  urea,	  1.5	  mM	  EDTA).	  Partial	  
alkaline	   hydrolysis	   reactions	   and	   denaturing	   RNase	   T1	   reactions	  were	   used	   as	   ladders.	   Partial	  
alkaline	   hydrolysis	   reactions	   were	   prepared	   by	   incubating	   RNA	   in	   reaction	   buffer	   (50	   mM	  
Na2CO3	   [pH	  9.0],	  1	  mM	  EDTA)	   for	  10	  min	  at	  95	   °C.	  Denaturing	  T1	   reactions	  were	  prepared	  by	  
incubating	  RNA	  with	  RNase	  T1	  (1U,	  Roche)	  for	  15	  min	  at	  55	  °C	  (25	  mM	  Na	  Citrate	  [pH	  5.0],	  5.5	  M	  
urea).	  10	  μL	  of	  each	  reaction	  and	  ladder	  was	  loaded	  on	  a	  12%	  denaturing	  Acrylamide/Bis	  gel	  and	  
run	   at	   35W	   at	   25	   °C.	   The	   gel	   was	   dried	   and	   examined	   using	   a	   GE	   Healthcare	   STORM	   820	  






SHAPE	  (selective	  2’-­‐hydroxyl	  acylation	  analyzed	  by	  primer	  extension)	  analysis	  
SHAPE	   was	   performed	   to	   further	   study	   the	   secondary	   structure	   of	   the	   predicted	   RNA.	   The	  
predicted	   RNA	   (rpsF_1-­‐69)	   with	   a	   3’	   end	   primer	   binding	   site	   was	   prepared	   as	   previously	  
described	  by	  in	  vitro	  transcription.	  The	  RNA-­‐protein	  dimer	  reaction	  	  and	  the	  no-­‐protein	  control	  
reaction	  were	  prepared	  as	  described	  above	  and	  incubated	  with	  3	  μL	  NMIA	  (130	  mM)	  for	  15	  min	  
at	   25	   °C	   to	   form	   acylated	   products.	   Modified	   RNAs	   were	   purified	   by	   phenol-­‐chloroform	  
extraction	   and	   ethanol	   precipitation	   and	   resuspended	   in	   10	   μL	   TE	   buffer	   (0.5X).	   Primer	  
extension	  was	  conducted	  by	  incubated	  the	  modified	  RNA	  with	  a	  5’-­‐labeled	  primer	  for	  30	  min	  at	  
55	  °C	  using	  Invitrogen	  Superscript	  III	  kit.	  Reverse	  transcription	  was	  stopped	  by	  addition	  of	  1	  μL	  
NaOH	   (4	  M)	   and	   29	   μL	   acid	   stop	  mix	   (Wilkinson	   et	   al.,	   2006).	   cDNAs	  were	   loaded	   on	   a	   10%	  
denaturing	  Acrylamide/Bis	  gel	  and	  run	  at	  55W	  at	  25	  °C.	  The	  gel	  was	  dried	  and	  examined	  using	  a	  
GE	   Healthcare	   STORM	   phosphorimager	   and	   SAFA	   footprinting	   software	   (Das	   et	   al.,	   2005;	  
Laederach	   et	   al.,	   2008).	   Data	   was	   normalized	   as	   previously	   described	   (Deigan	   et	   al.,	   2008;	  
Wilkinson	  et	  al.,	  2006).	  
	  
Chapter	  4	  
S.	  pombe	  lacZ	  reporter	  system	  
System	  setup	  
The	  S.	  pombe	  strain	  CHP902	  (h-­‐	  ura4-­‐D18	   leu1-­‐32)	  was	  a	  generous	  gift	   from	  Dr.	  Hoffman.	  DNA	  
sequences	   containing	   the	   minimal	   structure	   of	   each	   RNA	   element	   were	   PCR	   amplified	   from	  
bacterial	   genomic	   DNAs	   and	   integrated	   into	   pCHY24	   (Hoffman	   et	   al.,	   1989)	   through	   DMSO	  
transformation	   as	   previously	   described	   (Bähler	   et	   al.,	   1998).	   Recombinant	   plasmids	   were	  
isolated	   from	   yeast	   cells	   using	   “Smash	   and	   Grab”	   method	   (Hoffman	   et	   al.,	   1987)	   and	  
transformed	  into	  E.	  coli	  XL1-­‐Blue	  for	  sequencing.	  Sequences	  coding	  for	  each	  ribosomal	  protein	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were	  also	  PCR	  amplified,	   integrated	   into	  pNMT41	  (a	  gift	   from	  Dr.	  Hoffman),	  and	  sequenced	   in	  
the	  same	  way.	  Two	  plasmids	  were	  co-­‐transformed	  into	  S.	  pombe.	  
	  
β-­‐galactosidase	  assays	  
Individual	   colonies	   containing	   both	   plasmids	   were	   inoculated	   in	   YES-­‐uracil-­‐leucine	   media	  
overnight	  at	  30	  °C	  before	  sub-­‐cultured	   into	  EMM-­‐uracil-­‐leucine	  (8%	  glucose)	  with	  and	  without	  
thiamine	  (5	  μg/mL).	  Sub-­‐cultured	  cells	  were	  incubated	  for	  another	  24	  hours	  at	  30	  °C	  before	  sub-­‐
cultured	  again	  into	  EMM	  (0.1%	  glucose	  +	  3%	  glycerol)	  with	  and	  without	  thiamine	  (5	  μg/mL)	  for	  
3h	  at	  30	  °C	  to	  107	  cells/mL	  for	  β-­‐galactosidase	  assays.	  β-­‐galactosidase	  assays	  were	  performed	  as	  
previously	   describe	   (Rose	  &	  Botstein,	   1983).	   Protein	   concentrations	  were	  measured	  using	   the	  
BCA	   Protein	   Assay	   kit	   (Pierce).	   β-­‐galactosidase	   units	   =	  
!"!"#   ×  (!"#)!"#$   !"# ×!"#$!"  !"  !"#$%&#'   !" ×!"#$%&'  (!"/!")  .	  Data	  were	  analyzed	  using	  Excel.	  
	  
Dual	  luciferase	  reporter	  system	  
System	  setup	  
The	  dual	   luciferase	  reporter	  plasmid	  and	  protein	  overexprssion	  plasmid	  were	  constructed	  in	  E.	  
coli	   XL1-­‐Blue	   cells.	   pBAD33	   (ATCC)	   was	   modified	   to	   eliminate	   the	   NcoI	   site	   through	   silent	  
mutation	  (QuickChange	  Site-­‐Directed	  Mutagenesis	  Kit,	  Stratagene).	  The	  firefly	   luc+NF	  gene	  was	  
PCR	  amplified	  from	  pSP-­‐luc+NF	  (Promega)	  and	   inserted	   into	  the	  MCS	  of	  the	  modified	  pBAD33,	  
followed	   by	   an	   inserted	   rrnB	   terminator.	   A	   second	   promoter	   was	   inserted	   after	   the	   first	  
luciferase	  reporter	  cassette,	   followed	  by	  the	  renilla	   luc+NF	  gene	  (a	  gift	   from	  Dr.	  Gubbels),	  and	  
the	  native	  rrnB	   terminator	  on	  pBAD33.	  A	  93-­‐nt	  sequence	  and	  a	  69-­‐nt	  sequence	  containing	  the	  
L1-­‐binding	  structures	  from	  E.	  coli	  and	  G.	  kaustophilus,	  respectively,	  were	  PCR	  amplified	  from	  the	  
genomic	  DNAs,	  and	  the	  mutant	  forms	  were	  prepared	  in	  the	  same	  way.	  Sequence	  of	  the	  wildtype	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structure	   was	   inserted	   into	   the	   renilla	   luc-­‐NF	   cassette,	   whereas	   	   sequence	   of	   the	   mutant	  
structure	   was	   inserted	   into	   the	   firefly	   luc-­‐NF.	   The	   protein	   overexpression	   plasmid	   was	  
constructed	  with	  rplA	  	  (amplified	  from	  G.	  kaustophilus	  genomic	  DNA)	  inserted	  into	  pET-­‐HT.	  Two	  
plasmids	  were	  co-­‐transformed	  into	  E.	  coli	  BL21(DE3)	  (no	  plysY,	  NEB).	  	  
	  
Luciferase	  color	  assays	  
To	  perform	  dual	   luciferase,	   individual	   colonies	   that	  contain	  both	  plasmids	  were	  cultured	   in	  LB	  
media	  with	  antibiotics	  and	  L-­‐arabinose	  (15	  mM)	  for	  90	  min	  before	  IPTG	  induction	  (30	  μM).	  Cells	  
were	  collected	  1	  hour	  after	   IPTG	  induction	  and	  quick-­‐freezed	  at	  -­‐80	  °C.	  Luciferase	  assays	  were	  
conducted	   according	   to	   manufacturer’s	   protocols	   (Luciferase	   Assay	   System	   and	   Renilla	  
Luciferase	   Assay	   System,	   Promega).	   Data	   were	   collected	   using	   SpectraMax	   M3	   (Molecular	  
Devices).	   The	   ratio	  of	   renilla	   to	   firefly	   luciferase	   activity	   (Rluc	   /	   Fluc)	  was	   calculated	  using	   the	  
equation	  (!"#$%%&  !"#$%&'()&  !"#$%$#&/!"600) (!"#$!%&  !"#$%&'()&  !"#$%$#&/!"600).	  
	  
Chapter	  5	  
RNA	  target	  preparation	  
The	  G.	  kaustophilus	  RNAs	  were	  prepared	  as	  described	  above	  (Figure	  17).	  The	   last	  17	  nt	  of	   the	  
wildtype	  RNA	  was	  hybridized	  to	  a	  5’	  biotin-­‐tagged	  DNA	  (purchased	  from	  Eurofins)	  by	  mixing	  at	  
1:2.5	   molar	   ratio	   in	   50	   μL	   hybridization	   buffer	   (10	   mM	   Tris-­‐HCl,	   1	   mM	   EDTA,	   pH	   7.2)	   and	  
incubating	  for	  5	  min	  at	  95	  °C	  (Li	  et	  al.,	  2009).	  Hybridization	  was	  cooled	  down	  slowly	  to	  25	  °C	  and	  
examined	  on	  an	  8%	  nondenaturing	  acrylamide	  gel.	  
	  
	  
Phage	  display	  selection	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Phage	  display	  was	   conducted	   to	   select	   for	  heptapeptides	   that	   specifically	   interact	  with	   L1	  cis-­‐
regulatory	  RNA	  element	   from	  G.	  kaustophilus.	   The	  Ph.D.	   -­‐7	  Phage-­‐Display	  Peptide	  Library	  was	  
purchased	  from	  NEB	  and	  the	  methods	  were	  adapted	  from	  NEB	  protocol	  and	  previous	  studies	  (Li	  
et	  al.,	  2009;	  Llano-­‐Sotelo	  et	  al.,	  2009).	  The	  phage	  library	  (10	  μL,	  2×1013	  pfu/mL)	  was	  preselected	  
against	   the	   streptavidin-­‐coated	   magnetic	   beads	   (100	   μL,	   Invitrogen	   Dynabeads	   M-­‐280	  
Streptavidin)	   overnight	   at	   4	   °C	   in	   L1	   binding	   buffer	   (see	   L1	  methods)	   to	   remove	   streptavidin-­‐
binding	   phage.	   First	   round	   selection	   was	   conducted	   using	   the	   preselected	   phage	   library	   by	  
incubating	  with	  30	  pmol	  RNA	  targets	  in	  the	  presence	  of	  150	  pmol	  competitor	  tRNAs	  (Ribonucleic	  
acid,	   transfer,	   from	  baker’s	   yeast.	   Sigma)	   in	  100uL	   L1	  binding	  buffer	   for	   30	  min	  at	   25	   °C	  on	  a	  
rocker.	  After	  washing	  five	  times	  with	  washing	  buffer	  (L1	  binding	  buffer	  with	  0.3	  %	  Triton	  X-­‐100),	  
the	   RNA-­‐phage	   complexes	   were	   captured	   by	   adding	   0.1	   mg	   beads	   into	   the	   reaction	   and	  
incubating	   for	   another	   30	   min	   at	   25	   °C	   with	   rocking.	   Collected	   RNA-­‐phage	   complexes	   were	  
eluted	  by	  incubating	  with	  300	  pmol	  elution	  RNAs	  in	  100	  μL	  L1	  binding	  buffer	  for	  30	  min	  at	  25	  °C.	  
Eluted	  phage	  were	  amplified	  in	  E.	  coli	  ER2738	  (NEB)	  and	  titered	  before	  applied	  in	  the	  next	  round	  
of	  selection.	  The	  same	  methods	  were	  used	  throughout	  Round	  2-­‐4	  with	  increasing	  stringency	  in	  
the	  washing	  step	  and	  the	  addition	  of	  a	  nonspecific	  elution	  method	  (Table	  1),	  in	  which	  the	  RNA-­‐
phage	   complexes	   were	   incubated	   with	   100	   μL	   elution	   buffer	   (0.2	   M	   glycine-­‐HCl	   [pH	   2.2],	   1	  
mg/mL	  BSA)	  for	  9	  min	  at	  25	  °C	  followed	  by	  neutralization	  with	  15	  μL	  of	  1	  M	  Tris-­‐HCl,	  pH	  9.1.	  In	  
addition,	   in	  Round	  4,	   300	  pmol	  mutant	  RNA	   targets	  were	  added	   for	   counter-­‐selection	  and	  no	  
amplification	  was	  carried	  out.	  After	   the	   final	   round,	   individual	  phage	  plaques	  were	  picked	  out	  
and	  resuspended	  in	  water	  and	  were	  PCR	  amplified	  using	  a	  pair	  of	  phage	  sequencing	  primers	  (Li	  
et	  al.,	  2009).	  PCR	  products	  were	  sequenced	  to	  identify	  selected	  peptide	  sequences.	  	  
	  
Growth	  curve	  assays	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Growth	  curve	  assays	  were	  performed	  to	  investigate	  the	  effect	  of	  ribosomal	  proteins	  and	  
peptides	  overexpression	  on	  E.	  coli	  growth.	  Coding	  sequences	  of	  ribosomal	  proteins	  were	  PCR	  
amplified	  from	  bacteria	  genomic	  DNA	  and	  cloned	  onto	  pET-­‐HT.	  Coding	  sequences	  for	  selected	  
peptides	  with	  a	  N-­‐terminal	  start	  codon	  (ATG)	  were	  assembled	  by	  annealing	  complementary	  
primer	  pairs	  and	  inserted	  into	  pET-­‐HT	  as	  well.	  pET-­‐HT	  constructs	  were	  transformed	  into	  E.	  coli	  
BL21(DE3)	  strain.	  Individual	  colonies	  were	  cultured	  in	  LB	  media	  with	  antibiotics	  overnight	  at	  
37	  °C,	  which	  were	  then	  diluted	  with	  fresh	  media	  (OD600	  <	  0.01)	  with	  and	  without	  IPTG	  (1mM)	  
the	  next	  morning.	  Culture	  were	  incubated	  at	  37	  °C	  for	  4-­‐5	  hours	  and	  cell	  density	  was	  measured	  















Figure	   1.	   An	   overview	   of	   ribosomal	   protein	   regulation.	   	   To	  maintain	   a	   balance	  between	   the	  
level	  of	  rRNAs	  and	  the	   level	  of	  ribosomal	  proteins,	  expression	  of	  the	  ribosomal	  protein	  can	  be	  
autogenously	  regulated	  using	  a	  negative	  feedback	  mechanism.	  When	  rRNAs	  are	  saturated	  with	  
bound	   ribosomal	   proteins,	   excess	   ribosomal	   proteins	   can	   bind	   to	   a	   RNA	   regulatory	   element	  
associated	   with	   its	   operon	   to	   stop	   transcription	   or	   translation.	   Because	   multiple	   ribosomal	  
proteins	  are	  often	  arranged	   in	   the	  same	  operon,	  one	  regulatory	  mechanism	  can	  control	  many	  

















Figure	   2.	   Phylogenetic	   distribution	   of	   E.	   coli	   r-­‐protein	   regulatory	   RNAs.	   (A)	   Distribution	   of	  
ribosomal	  protein	  autogenous	  regulatory	  RNAs	  in	  bacterial	  phyla.	  (B)	  Distribution	  of	  regulatory	  





Figure	   3.	   Regulation	   models	   of	   L1	   biosynthesis	   in	   E.	   coli	   and	   Archaea.	   Transcriptional	  
organization	   and	   regulation	   of	   L1-­‐related	   genes.	   (A)	   E.	   coli;	   (B)	   Archaea.	   Regulatory	   RNA	  





















Figure	  4.	  Consensus	   sequence	  and	   secondary	   structure	   for	   r-­‐protein	   L1	   regulatory	  RNA.	  This	  
diagram	  indicates	  the	  conserved	  secondary	  structure	  and	  sequence	  of	  the	  RNA	  motif.	  Base	  pairs	  
supported	   by	   covariation	   are	   indicated	   by	   green	   shading	   only	   if	   Watson-­‐Crick	   pairing	   occurs	  




















Figure	  5.	  Multiple	  regulation	  model	  of	  ribosomal	  protein	  L1.	   	  The	  L1	  binding	  site	  is	  commonly	  
found	  before	  the	  rplK	  gene	  or	  before	  rplA.	  However,	  in	  Firmicutes,	  as	  represented	  by	  B.	  subtilis	  
and	  G.	  kaustophilus,	  the	  L1	  binding	  site	  is	  located	  before	  both	  of	  the	  rplK	  and	  rplA	  genes,	  which	  



















Figure	  6.	  L1-­‐binding	  RNA	  structures	   from	  G.	  kaustophilus.	   	   (A)	  G.	  kaustophilus	  RNA	  preceding	  
rplK.	   (B)	   G.	   kaustophilus	   RNA	   preceding	   rplA.	   The	   guanosine	   marked	   by	   *	   were	   mutated	   to	  
adenosine	   to	   create	  negative	   control	   RNAs.	   Interactions	   between	   the	  RNAs	   and	   L1	  protein	   as	  
measured	   by	   filter-­‐binding	   assays.	   RNAs	   pictured	   in	   parts	   A	   and	   B	   are	   represented	   by	   filled	  
squares	   and	   circles,	   respectively.	   Their	  mutants	   are	   represented	   by	   open	   symbols.	   Error	   bars	  











Figure	  7.	  Known	  transcriptional	  organizations	  of	  the	  S6	  operon.	  	  (A)	  Represented	  by	  E.	  coli	  and	  
T.	   thermophilus	   (with	   the	   middle	   gene	   unannotated).	   (B)	   Represented	   by	   B.	   subtilis	   and	   G.	  




















Figure	  8.	  S6	  operon-­‐associated	  RNA	  secondary	  structures.	   	  (A)	  Consensus	  secondary	  structure	  
of	   the	   RNA	  motif	   preceding	   rpsF	   derived	   from	  more	   than	   1300	   sequences.	   This	   RNA	  motif	   is	  
widely	  distributed	  across	  many	  bacterial	  phyla.	  (B)	  Example	  of	  the	  RNA	  motif	  from	  B.	  subtilis	  169.	  
The	  transcription	  start	  site,	  an	  alternative	  pairing	  element,	  and	  potential	  regulatory	  features	  are	  
indicated.	   (C)	  Consensus	   secondary	   structure	   for	   the	  more	   than	  500	  RNA	   sequences	  primarily	  
identified	   from	  Firmicutes	  and	  Actinobacteria	   that	   contain	   a	  potential	   conserved	  H3	  helix.	   (D)	  
rRNA	   binding	   site	   for	   the	   S6:S18	   complex.	   Sequence	   >98%	   across	   4214	   bacterial	   16S	   rRNA	  
sequences	   (Cannone	   et	   al.,	   2002).	   Bases	   in	   contact	  with	   S18	   in	   T.	   thermophilus	   structure	   are	  







Figure	  9.	   rpsF_5-­‐69	   titrations.	   	   (A)	  Gel-­‐shift	  of	  rpsF_5-­‐69	  with	   increasing	  concentration	  of	  S18	  
(0nM,	  19-­‐600	  nM).	  (B)	  Gel-­‐shift	  of	  rpsF_5-­‐69	  with	  increasing	  concentration	  of	  S6	  (0	  nM,	  9.7-­‐600	  
nM).	   (C)	   Gel-­‐shift	   of	   rpsF_5-­‐69	   with	   increasing	   S6	   and	   S18	   (mixed	   1:1,	   0	   nM,	   9.7-­‐600	   nM).	  
Arrows	  indicate	  quantified	  bands.	  (D)	  Quantification	  of	  the	  fraction	  of	  rpsF_5-­‐69	  bound	  by	  the	  
protein	   with	   S6,	   S18,	   and	   S6:S18.	   Error	   bars	   represent	   standard	   deviation	   on	   three	   to	   six	  
independent	   experiments.	   Some	   error	   bars	   fall	   within	   the	   boundaries	   of	   the	   marker.	   Curve	  















Figure	  10.	  rpsF_5-­‐69	  titrations	  with	  one	  of	  S6:S18	  at	  constant	  concentration.	   	   (A)	  Gel-­‐shift	  of	  
rpsF_5-­‐69	  with	  500	  nM	  S18	  and	  increasing	  concentration	  of	  S6	  (no	  protein,	  0nM	  S6,	  4.6	  –	  500	  
nM	  S6).	   (B)	  Gel-­‐shift	  of	   rpsF_5-­‐69	  with	  600	  nM	  S6	  and	   increasing	  concentration	  of	  S18	  (0	  nM,	  
18.5	  –	  600	  nM	  S18,	  no	  protein).	  Arrows	  on	  A	  and	  B	  indicate	  quantified	  bands.	  (C)	  Quantification	  
of	   the	   fraction	  of	   rpsF_5-­‐69	  bound	  by	   the	  S6:S18	  complex.	   Solid	   thick	   line	  corresponds	   to	   the	  
titration	  of	  S6:S18	  mixed	  in	  equal	  amount	  (KD	  of	  37	  nM,	  Hill	  coefficient	  1.45,	  maximum	  fraction	  
bound	  93.5%).	  Dashed	  line	  is	  the	  curve	  fit	  of	  the	  S6	  titration	  (Kd	  =	  37	  nM,	  Hill	  coefficient	  =	  1.45,	  
maximum	  fraction	  bound	  93.5%).	  Thin	  line	  is	  the	  curve	  fit	  for	  the	  S18	  titration	  (Kd	  =	  60	  nM,	  Hill	  















Figure	   11.	  Mutant	   RNA	   titrations.	   	   (A)	  The	  RNA	  construct	   rpsF_5-­‐69	  used	   for	   in	  vitro	  binding	  
assays	  with	  mutations	   indicated.	   (B)	   Interactions	  of	   S6:S18	  with	  mutants	  displayed	   in	  A.	   Solid	  
black	  curve	  is	  plotted	  for	  M6	  (Kd	  =	  115	  nM,	  Hill	  coefficient	  =	  3).	  For	  the	  remaining	  mutants	  RNA	  

















Figure	   12.	   S6:S18	   preferentially	   interacts	   with	   H2	   of	   predicted	   RNA	   structure.	   	   (A)	   Highly	  
reactive	   (black	   circles)	   and	   moderately	   reactive	   (gray	   circles)	   nucleotides	   determined	   from	  
SHAPE	  analysis	   of	  RNA	   in	   isolation	  mapped	   to	   the	   rpsF_1-­‐69	   structure.	   Positions	  not	   resolved	  
are	  in	  gray.	  (B)	  Reactive	  nucleotides	  in	  SHAPE	  analysis	  of	  RNA	  bound	  to	  the	  S6:S18	  complex.	  (C)	  
Nuclease	   probing	   data	   mapped	   to	   the	   secondary	   structure	   of	   the	   rpsF_5-­‐69	   RNA	   structure.	  
Starred	  bases	  are	  cleaved	  by	  V1	  nuclease	  and	  arrows	  indicate	  bases	  cleaved	  by	  RNase	  A.	  Bases	  
protected	  from	  cleavage	  by	  the	  addition	  of	  protein	  are	  circled.	  Bases	  not	  resolved	  on	  the	  gel	  are	  
in	   gray.	   Numbering	   starts	   from	   the	   transcription	   start	   site	   (A).	   (D,E)	   Nuclease	   probing	   gels	   of	  
rpsF_5-­‐69.	  (D)	  and	  rpsF_5-­‐69	  M4	  (E)	  using	  RNase	  A	  (left),	  which	  cleaves	  single-­‐stranded	  uridine	  
and	   cytosine,	   and	   RNase	   V1	   (right),	   which	   cleaves	   double-­‐stranded	   RNA.	   RNA	  was	   incubated	  
with	  increasing	  concentrations	  of	  S6	  and	  S18	  mixed	  at	  a	  1:1	  ratio.	  (F)	  V1	  nuclease	  probing	  gel	  of	  
rpsF_5-­‐69	  in	  the	  presence	  of	  S18	  alone.	  OH−	  and	  T1	  lanes	  indicate	  partial	  alkaline	  hydrolysis	  and	  
RNase	   T1	   digest	   under	   denaturing	   conditions	   used	   to	   map	   the	   RNA	   sequence.	   On	   the	   right,	  
bases	  cleaved	  by	  RNase	  V1	  are	  indicated.	  On	  the	  left,	  nucleotides	  cleaved	  by	  RNase	  T1	  (G)	  and	  






Figure	   13.	   SHAPE	   experiment	   for	   rpsF_1-­‐69.	   	   The	   experiment	   was	   done	   as	   described	   in	  
Materials	  and	  Methods	  section.	  T,	  C,	  and	  A	  are	  sequencing	  reactions	  performed	  using	  adenosine,	  
guanine,	   and	   thymidine	   dideoxy	   terminating	   nucleotides.	   The	   middle	   panel	   is	   shown	   with	  




Figure	  14.	  Varied	  reporter	  activities	  seen	  with	  E.	  coli	  S15-­‐RNA	  interaction	   in	  S.	  pombe.	   	  Each	  
number	  represents	  an	  individual	  colony.	  Black	  columns	  show	  β-­‐galactosidase	  unit	  measured	  for	  
yeast	   cells	   with	   thiamine	   (5	   μg/mL)	   –	   repressed	   S15	   overexpression;	   	   grey	   columns	   	   show	   β-­‐
galactosidase	  unit	  measured	  for	  yeast	  cells	  with	  de-­‐repressed	  S15	  overexpression.	  The	  RNA-­‐lacZ	  
translational	  fusion	  expression	  was	  de-­‐repressed	  in	  all	  cultures	  in	  the	  presence	  of	  0.1%	  glucose	  

















Figure	   15.	   A	   schematic	   of	   the	   dual-­‐luciferase	   reporter	   plasmid.	   	   The	   reporter	   plasmid	   was	  
modified	   from	   pBAD33.	   Arrows	   represent	   the	   L-­‐arabinose-­‐inducible	   promoters.	   Black	   squares	  
represent	  rrnB	  terminators.	  Black	  and	  grey	  open	  circles	  represent	  the	  wildtype	  and	  mutated	  E.	  
coli	  L1	   regulatory	  RNA	  motif,	  respectively.	  Each	  RNA	  motif	  and	  the	  following	   luciferase	  gene	   is	  
























Figure	  16.	  Varied	  reporter	  activities	  seen	  with	  G.	  kaustophilus	  L1-­‐RNA	  interaction	  in	  E.	  coli.	  	  
Each	  number	  represents	  an	  individual	  colony.	  Black	  columns	  represent	  cultures	  without	  IPTG	  
induction;	  grey	  columns	  represent	  cultures	  with	  IPTG	  induction	  (30	  μM)	  for	  1	  h.	  The	  data	  are	  












Figure	  17.	  G.	  kaustophilus	  RNAs	  used	  in	  the	  phage	  display	  selections.	  	  (A)	  r-­‐protein	  L1-­‐binding	  
RNA	   target	   (62-­‐nt)	   hybridized	   to	   a	   biotin	   tag	   at	   the	   3’	   end.	   	   (B)	   L1-­‐binding	   RNA	   (39-­‐nt)	   for	  
specific	   elution.	   (C)	  Mutated	   RNA	   (39-­‐nt)	   with	   abolished	   L1-­‐binding	   ability	   for	   Round	   4.	   The	  
native	  Shine-­‐Dalgarno	  sequence	  is	   labeled	  in	  grey;	  the	  native	  start	  codon	  is	   labeled	  in	  red.	  The	  















Figure	  18.	  E.	  coli	  BL21(DE3)	  growth	  curves	  for	  peptide	  overexpression.	  	  (A)	  N-­‐FSGGGNH-­‐C.	  (B)	  
N-­‐FSGGGNHGGGS-­‐C.	  (C)	  N-­‐TVNFKLY-­‐C.	  (D)	  N-­‐TVNFKLYGGGS-­‐C.	  (E)	  N-­‐YLKFNVT-­‐C.	  (F)	  N-­‐NYSYIPP-­‐
C.	   (G)	   N-­‐NYSYIPPGGGS.	   Black	   circles	   represent	   negative	   controls	   without	   peptides	  














Figure	   19.	   E.	   coli	   BL21(DE3)	   growth	   curves	   for	   r-­‐protein	   overexpression.	   	   (A)	   Empty	   pET-­‐HT	  
vector.	  (B)	  G.	  kaustophilus	  L1.	  (C)	  G.	  kaustophilus	  S18.	  (D)	  G.	  kaustophilus	  S6.	  (E)	  G.	  kaustophilus	  
S15.	   Black	   circles	   represent	   negative	   controls	  without	   peptides	   overexpression;	   open	   squares	  












Table	  1.	  Primers	  for	  RACE.	  
L1	  operon	  5’	  RACE	  
Gene-­‐specific	  primer	  rplK	  1	   5’-­‐AGCAATACTGCAGCAGGTGGAGTT	  
Gene-­‐specific	  primer	  rplA	  1	   5’-­‐TGCGAAAACGAGAACGCGCTGAGT	  
5’-­‐linker	   5’-­‐GACTGGAGCACGAGGACACTGA	  
Gene-­‐specific	  primer	  rplK	  2	   5’-­‐CCAACTGGTGGTGCTGGGTTAGC	  
Gene-­‐specific	  primer	  rplA	  2	   5’-­‐CGGTCTACAAGCTTAGCAGCTTCA	  
S6	  operon	  5’	  RACE	  
Gene-­‐specific	  primer	  rpsF	  1	   5’-­‐ACCCAATCCTTTGTTCCAGTG	  
Gene-­‐specific	  primer	  rpsR	  1	   5’-­‐CATCTACATCTTTGTAGTCGATGTGC	  
Gene-­‐specific	  primer	  rpsF	  2	   5’-­‐GACTCTTCGTCAATGTTTGGGCGG	  
Gene-­‐specific	  primer	  rpsR	  2	   5’-­‐CGCACGACCGCCTCTGCGTCCTC	  
S6	  operon	  3’	  RACE	  
dT	  pirmer	   5’-­‐GCGGTCACGCTTACTTAGCCCTCACTGAAATTTTTTTTTTTTTTTTT	  
Gene-­‐specific	  primer	  	   5’-­‐GATCAAACGCGCACGTCAAATGG	  



















Table	  2.	  Phage	  display	  selection	  setups.	  
Round	  	   Washing	  	   Competitor	  RNA	  	   Elution	  method	  	  
1	  	   5	  times;	  0.3%	  Triton	  X-­‐100	  	   1.5	  nmol	  tRNA	  	   Specific	  	  
2	  	   5	  times;	  0.3%	  Triton	  X-­‐100	  	   1.5	  nmol	  tRNA	  	   Low-­‐pH;	  specific	  	  
3	  	   5	  times;	  0.5%	  Triton	  X-­‐100	  	   1.5	  nmol	  tRNA	  	   Low-­‐pH;	  specific	  
4	  	   10	  times;	  0.5%	  Triton	  X-­‐
100	  	  
1.5	  nmol	  tRNA;	  	  




















Table	  3.	  Selected	  peptides.	  
Elution	  method	  	   Selection	  1	  	   Selection	  2	  	  






(1)	  N-­‐HPRLRKH-­‐C	  	  
Specific	  	   (8)	  N-­‐FSGGGNH-­‐C	  
(1)	  N-­‐NYSYIPP-­‐C	  



















Agalarov,	  S.	  C.,	  Prasad,	  G.	  S.,	  Funke,	  P.	  M.,	  Stout,	  C.	  D.,	  &	  Williamson,	  J.	  R.	  (2000).	  Structure	  of	  
the	   S15,S6,S18-­‐rRNA	   Complex:	   Assembly	   of	   the	   30S	   Ribosome	   Central	   Domain.	   Science,	  
288(5463),	  107–112.	  
Akanuma,	  G.,	  Nanamiya,	  H.,	  Natori,	  Y.,	  Yano,	  K.,	  Suzuki,	  S.,	  Omata,	  S.,	  Ishizuka,	  M.,	  Sekine,	  Y.	  and	  
Kawamura,	   F.	   (2012).	   Inactivation	   of	   ribosomal	   protein	   genes	   in	   Bacillus	   subtilis	   reveals	  
importance	  of	  each	  ribosomal	  protein	  for	  cell	  proliferation	  and	  cell	  differentiation.	  Journal	  
of	  Bacteriology,	  194(22),	  6282–91.	  
Ameres,	  S.	  L.,	  Shcherbakov,	  D.,	  Nikonova,	  E.,	  Piendl,	  W.,	  Schroeder,	  R.,	  &	  Semrad,	  K.	  (2007).	  RNA	  
chaperone	   activity	   of	   L1	   ribosomal	   proteins:	   phylogenetic	   conservation	   and	   splicing	  
inhibition.	  Nucleic	  Acids	  Research,	  35(11),	  3752–3763.	  
Aseev,	  L.	  V,	  Levandovskaya,	  A.	  A.,	  Tchufistova,	  L.	  S.,	  Scaptsova,	  N.	  V,	  &	  Boni,	  I.	  V.	  (2008).	  A	  new	  
regulatory	   circuit	   in	   ribosomal	   protein	   operons :	   S2-­‐mediated	   control	   of	   the	   rpsB-­‐tsf	  
expression	  in	  vivo.	  RNA,	  14(9),	  1882–1894.	  
Bähler,	  J.,	  Wu,	  JQ.,	  Longtine,	  MS.,	  Shah,	  NG.,	  McKenzie,	  A.,	  Steever,	  AB.,	  Wach,	  A.,	  Philippsen,	  P.	  
and	  Pringle,	  J.	  R.	  (1998).	  Heterologous	  modules	  for	  efficient	  and	  versatile	  PCR-­‐based	  gene	  
targeting	  in	  Schizosaccharomyces	  pombe.	  Yeast	  (Chichester,	  England),	  14(10),	  943–51.	  
Baughman,	   G.,	   &	   Nomura,	   M.	   (1984).	   Translational	   regulation	   of	   the	   L11	   ribosomal	   protein	  
operon	  of	  Escherichia	  coli:	  analysis	  of	  the	  mRNA	  target	  site	  using	  oligonucleotide-­‐directed	  
mutagenesis.	  PNAS,	  81(17),	  5389–5393.	  
Biorn,	  AC.,	  Cocklin,	  S.,	  Madani,	  N.,	  Si,	  Z.,	  Ivanovic,	  T.,	  Samanen,	  J.,	  Van	  Ryk, DI., Pantophlet,	  R.,	  
Burton,	   DR.,	   Freire,	   E.,	   Sodroski,	   J.	   and	   Chaiken,	   I.	  M.	   (2004).	  Mode	   of	   action	   for	   linear	  
peptide	  inhibitors	  of	  HIV-­‐1	  gp120	  interactions.	  Biochemistry,	  43(7),	  1928–1938.	  
Block,	  K.	  F.,	  Puerta-­‐Fernandez,	  E.,	  Wallace,	  J.	  G.,	  &	  Breaker,	  R.	  R.	  (2011).	  Association	  of	  OLE	  RNA	  
with	  bacterial	  membranes	  via	  an	  RNA-­‐protein	   interaction.	  Molecular	  Microbiology,	  79(1),	  
21–34.	  
Brodersen,	   D.	   E.,	   Clemons,	   W.	   M.,	   Carter,	   a	   P.,	   Morgan-­‐Warren,	   R.	   J.,	   Wimberly,	   B.	   T.,	   &	  
Ramakrishnan,	  V.	  (2000).	  The	  structural	  basis	  for	  the	  action	  of	  the	  antibiotics	  tetracycline,	  
pactamycin,	  and	  hygromycin	  B	  on	  the	  30S	  ribosomal	  subunit.	  Cell,	  103(7),	  1143–1154.	  
Cannone,	  JJ., Subramanian,	  S., Schnare,	  MN., Collett,	  JR., D'Souza,	  LM., Du,	  Y., Feng,	  B., Lin,	  N., 
Madabusi,	   LV., Müller,	   KM., Pande,	   N., Shang,	   Z., Yu,	   N. and Gutell,	   RR.	   (2002).	   The	  
comparative	   RNA	   web	   (CRW)	   site:	   an	   online	   database	   of	   comparative	   sequence	   and	  
structure	  information	  for	  ribosomal,	  intron,	  and	  other	  RNAs.	  BMC	  Bioinformatics,	  3,	  2.	  
Carter,	  A.,	  Clemons,	  W.,	  Brodersen,	  D.,	  Morgan-­‐Warren,	  R.,	  Wimberly,	  B.,	  &	  Ramakrishnan,	  V.	  
(2000).	   Functional	   insights	   from	   the	   structure	   of	   the	   30S	   ribosomal	   subunit	   and	   its	  
interactions	  with	  antibiotics.	  Nature,	  407(6802),	  340–348.	  
64	  
	  
Cheng,	   X.,	   Kay,	   B.	   K.,	   &	   Juliano,	   R.	   L.	   (1996).	   Identification	   of	   a	   biologically	   significant	   DNA-­‐
binding	  peptide	  motif	  by	  use	  of	  a	  random	  phage	  display	  library.	  Gene,	  171(1),	  1–8.	  
Choonee,	  N.,	  Even,	  S.,	  Zig,	  L.,	  Putzer,	  H.,	  Upr,	  C.,	  &	  Physico-­‐chimique,	  I.	  D.	  B.	  (2007).	  Ribosomal	  
protein	   L20	   controls	   expression	   of	   the	   Bacillus	   subtilis	   infC	   operon	   via	   a	   transcription	  
attenuation	  mechanism.	  Nucleic	  Acids	  Research,	  35(5),	  1578–1588.	  
Culver,	   G.,	   &	   Noller,	   H.	   (1999).	   Efficient	   reconstitution	   of	   functional	   Escherichia	   coli	   30S	  
ribosomal	  subunits	   from	  a	  complete	  set	  of	  recombinant	  small	  subunit	  ribosomal	  Efficient	  
reconstitution	  of	  functional	  Escherichia	  coli	  30S	  ribosomal	  subunits	  from	  a	  complete	  set	  of	  
recombinant	  sma.	  RNA,	  5,	  832–843.	  
Cwirla,	   S.,	   Peters,	   E.,	   Barrett,	   R.,	   &	   Dower,	   W.	   (1990).	   Peptides	   on	   phage:	   a	   vast	   library	   of	  
peptides	  for	  identifying	  ligands.	  PNAS,	  87(16),	  6378–82.	  
Danner,	  S.,	  &	  Belasco,	  J.	  (2001).	  T7	  phage	  display :	  A	  novel	  genetic	  selection	  system	  for	  cloning	  
RNA-­‐binding	  proteins	  from	  cDNA	  libraries.	  PNAS,	  98(23),	  12954–12959.	  
Das,	  R.,	  Laederach,	  A.,	  Pearlman,	  S.,	  Herschlag,	  D.,	  &	  Altman,	  R.	  (2005).	  SAFA :	  Semi-­‐automated	  
footprinting	   analysis	   software	   for	   high-­‐throughput	   quantification	   of	   nucleic	   acid	  
footprinting	   experiments	   SAFA :	   Semi-­‐automated	   footprinting	   analysis	   software	   for	   high-­‐
throughput	  quantification	  of	  nucleic	  acid	  footprinting	  experimen.	  RNA,	  11,	  344–354.	  
Dean,	  D.,	  &	  Nomura,	  M.	   (1980).	   Feedback	   regulation	  of	   ribosomal	   protein	   gene	  expression	   in	  
Escherichia	  coli.	  PNAS,	  77(6),	  3590–4.	  
Deigan,	  K.	  E.,	   Li,	  T.	  W.,	  Mathews,	  D.	  H.,	  &	  Weeks,	  K.	  M.	   (2008).	  Accurate	  SHAPE-­‐directed	  RNA	  
structure	  determination	  a	  SHAPE	  experiment	  can	  be	   interpreted	  as	  a	  pseudo-­‐free	  energy	  
high	  accuracy	  .	  Free	  energy	  minimization	  ,	  by	  using	  SHAPE	  pseudo-­‐.	  PNAS,	  106(1),	  97–102.	  
Devlin,	   J.,	   Panganiban,	   L.,	   &	   Devlin,	   P.	   (1990).	   Random	   peptide	   libraries:	   a	   source	   of	   specific	  
protein	  binding	  molecules.	  Science,	  249(4967),	  404–6.	  
Fu,	   Y.,	   Deiorio-­‐Haggar,	   K.,	   Anthony,	   J.,	   &	  Meyer,	   M.	   (2013).	   Most	   RNAs	   regulating	   ribosomal	  
protein	  biosynthesis	  in	  Escherichia	  coli	  are	  narrowly	  distributed	  to	  Gammaproteobacteria.	  
Nucleic	  Acids	  Research,	  41(6),	  3491–503.	  
Fu,	  Y.,	  Deiorio-­‐Haggar,	  K.,	  Soo,	  M.,	  &	  Meyer,	  M.	  (2014).	  Bacterial	  RNA	  motif	  in	  the	  5’	  UTR	  of	  rpsF	  
interacts	  with	  an	  S6:S18	  complex.	  RNA,	  20(2),	  168–176.	  
Goldmann,	  D.	  A.	  (1992).	  The	  crisis	  in	  antibiotic	  resistance.	  Science,	  30(1),	  20–24.	  
Gourse,	  R.,	  &	  Nomura,	  M.	   (1984).	   Level	  of	   rRNA,	  not	   tRNA,	   synthesis	   controls	   transcription	  of	  
rRNA	  and	  tRNA	  operons	  in	  Escherichia	  coli.	  Journal	  of	  Bacteriology,	  160(3),	  1022–6.	  
65	  
	  
Gourse,	  R.,	  Thurlowt,	  D.,	  Gerbi,	  S.,	  &	  Zimmermannt,	  R.	  (1981).	  Specific	  binding	  of	  a	  prokaryotic	  
ribosomal	   protein	   to	   a	   eukaryotic	   ribosomal	   RNA:	   implications	   for	   evolution	   and	  
autoregulation.	  PNAS,	  78(5),	  2722–2726.	  
Grentzmann,	   G.,	   Ingram,	   J.,	   Kelly,	   P.,	   Grentzmann,	   G.,	   Ingram,	   J.,	   Kelly,	   P.,	   Gesteland,	   R.	   and	  
Atkins,	   J.	   (1998).	  A	  dual-­‐luciferase	   reporter	  system	  for	  studying	   recoding	  signals	   .	  A	  dual-­‐
luciferase	  reporter	  system	  for	  studying	  recoding	  signals.	  RNA,	  4,	  479–486.	  
Grundy,	   F.	   J.,	   &	   Henkin,	   T.	   M.	   (1991).	   The	   rpsD	   gene,	   encoding	   ribosomal	   protein	   S4,	   is	  
autogenously	  regulated	  in	  Bacillus	  subtilis.	  Journal	  of	  Bacteriology,	  173(15),	  4595–602.	  
Guillier,	  M.,	  Allemand,	  F.,	  &	  Raibaud,	  S.	  (2002).	  Translational	  feedback	  regulation	  of	  the	  gene	  for	  
L35	   in	  Escherichia	  coli	  requires	  binding	  of	  ribosomal	  protein	  L20	  to	  two	  sites	   in	   its	   leader	  
mRNA:	   a	   possible	   case	   of	   ribosomal	   RNA-­‐messenger	   RNA	  molecular	  mimicry.	  RNA,	  8(7),	  
878–889.	  
Hanner,	  M.,	  Mayer,	  C.,	  Köhrer,	  C.,	  Golderer,	  G.,	  Gröbner,	  P.,	  &	  Piendl,	  W.	   (1994).	  Autogenous	  
translational	   regulation	   of	   the	   ribosomal	   MvaL1	   operon	   in	   the	   archaebacterium	  
Methanococcus	  vannielii.	  Journal	  of	  Bacteriology,	  176(2),	  409–18.	  
Harger,	  J.,	  Dinman,	  J.,	  Harger,	  J.,	  &	  Dinman,	  J.	  (2003).	  An	  in	  vivo	  dual-­‐luciferase	  assay	  system	  for	  
studying	   translational	   recoding	   in	   the	   yeast	   Saccharomyces	   cerevisiae	   An	   in	   vivo	   dual-­‐
luciferase	   assay	   system	   for	   studying	   translational	   recoding	   in	   the	   yeast	   Saccharomyces	  
cerevisiae.	  RNA,	  9,	  1019–1024.	  
Held,	  W.,	  Ballou,	  B.,	  &	  Nomura,	  M.	  (1974).	  Assembly	  Mapping	  of	  30	  S	  Ribosomal	  Proteins	  from	  
Escherichia	   coli :	   FURTHER	   STUDIES	   Assembly	   Proteins	  Mapping	   of	   30	   S	   Ribosomal	   from	  
Escherichia	  coli.	  Journal	  of	  Biological	  Chemistry,	  249,	  3103–3111.	  
Hoffman,	   C.	   S.,	   &	   Winston,	   F.	   (1987).	   A	   ten-­‐minute	   DNA	   preparation	   from	   yeast	   efficiently	  
releases	  autonomous	  plasmids	  for	  transformation	  of	  Escherichia	  coli.	  Gene,	  57(2-­‐3),	  267–
272.	  
Hoffman,	   C.	   S.,	   &	  Winston,	   F.	   (1989).	   A	   transcriptionally	   regulated	   expression	   vector	   for	   the	  
fission	  yeast	  Schizosaccharomyces	  pombe.	  Gene,	  84,	  473–479.	  
Isono,	   K.,	   &	   Kitakawa,	   M.	   (1978).	   Cluster	   of	   ribosomal	   protein	   genes	   in	   Escherichia	   coli	  
containing	  genes	  for	  proteins	  S6,	  S18,	  and	  L9.	  PNAS,	  75(12),	  6163–6167.	  
J	   M	   Zengel,	   L.	   L.	   (1994).	   Diverse	   Mechanisms	   for	   Regulation	   Ribosomal	   Protein	   Synthesis	   in	  
E.coli.pdf.	  PNAS,	  47,	  331–370.	  
Jaskunas,	   SR.,	   Fallon,	   ANNM.,	   Nomura,	   M.,	   &	   Blattner,	   FR.	   (1977).	   Expression	   of	   Ribosomal	  
Protein	  Vector	  Phages	  and	  Identification	  Genes	  Cloned	  in	  Charon	  of	  Their	  Promoters.	  The	  
Journal	  of	  Biological	  Chemistry,	  252(20),	  7355–7364.	  
66	  
	  
Knowles,	   D.,	   Foloppe,	   N.,	   Matassova,	   N.,	   &	   Murchie,	   A.	   (2002).	   The	   bacterial	   ribosome	   ,	   a	  
promising	   focus	   for	   structure-­‐based	   drug	   design.	  Current	  Opinion	   in	   Pharmacology,	  2(5),	  
501–506.	  
Köhrer,	  C.,	  Mayer,	  C.,	  Neumair,	  O.,	  Gröbner,	  P.,	  &	  Piendl,	  W.	  (1998).	  Interaction	  of	  ribosomal	  L1	  
proteins	   from	  mesophilic	  and	   thermophilic	  Archaea	  and	  Bacteria	  with	   specific	   L1-­‐binding	  
sites	  on	  23S	  rRNA	  and	  mRNA.	  FEBS,	  256(1),	  97–105.	  
Kraft,	  A.,	  Lutz,	  C.,	  Lingenhel,	  A.,	  Gröbner,	  P.,	  &	  Piendl,	  W.	  (1999).	  Control	  of	  ribosomal	  protein	  L1	  
synthesis	  in	  mesophilic	  and	  thermophilic	  archaea.	  Genetics,	  152(4),	  1363–72.	  
Laederach,	  A.,	  Das,	  R.,	  Vicens,	  Q.,	  Pearlman,	  S.,	  Brenowitz,	  M.,	  Herschlag,	  D.,	  &	  Altman,	  R.	  (2008).	  
Semiautomated	   and	   rapid	   quantification	   of	   nucleic	   acid	   footprinting	   and	   structure	  
mapping	  experiments.	  Nature	  Protocols,	  3(9),	  1395–401.	  
Li,	   M.,	   Duc,	   AE.,	   Klosi,	   E.,	   Pattabiraman,	   S.,	   Spaller,	   MR.,	   &	   Chow,	   CS.	   (2009).	   Selection	   of	  
peptides	  that	  target	  the	  aminoacyl-­‐tRNA	  site	  of	  bacterial	  16S	  ribosomal	  RNA.	  Biochemistry,	  
48(35),	  8299–8311.	  
Lindahl,	  L.,	  Post,	  L.,	  Zengel,	  J.,	  Gilbert,	  S.	  F.,	  Strycharz,	  W.	  a,	  &	  Nomura,	  M.	  (1977).	  Mapping	  of	  
ribosomal	  protein	  genes	  by	  in	  vitro	  protein	  synthesis	  using	  DNA	  fragments	  of	  lambdafus3	  
transducing	  phage	  DNA	  as	  templates.	  The	  Journal	  of	  Biological	  Chemistry,	  252(20),	  7365–
83.	  
Llano-­‐Sotelo,	   B.,	   Klepacki,	   D.,	   &	   Mankin,	   A.	   (2009).	   Selection	   of	   small	   peptides,	   inhibitors	   of	  
translation.	  Journal	  of	  Molecular	  Biology,	  391(5),	  813–9.	  
Marzi,	  S.,	  Myasnikov,	  AG.,	  Serganov,	  A.,	  Ehresmann,	  C.,	  Romby,	  P.,	  Yusupov,	  M.,	  &	  Klaholz,	  BP.	  
(2007).	  Structured	  mRNAs	  regulate	  translation	  initiation	  by	  binding	  to	  the	  platform	  of	  the	  
ribosome.	  Cell,	  130(6),	  1019–1031.	  
Mcnabb,	   D.,	   Reed,	   R.,	   &	   Marciniak,	   R.	   (2005).	   Dual	   Luciferase	   Assay	   System	   for	   Rapid	  
Assessment	  of	  Gene	  Expression	   in	  Saccharomyces	  cerevisiae.	  Eukaryotic	  Cell,	  4(9),	  1539–
1549.	  
Nevskaya,	  N.,	  Tishchenko,	  S.,	  Volchkov,	  S.,	  Kljashtorny,	  V.,	  Nikonova,	  E.,	  Nikonov,	  O.,	  Nikulin,	  A.,	  
Köhrer,	   C.,	   Piendl,	  W.,	   Zimmermann,	   R.,	   Stockley,	   P.,	  Garber,	  M.	   and	  Nikonov,	   S.	   (2006).	  
New	   insights	   into	   the	   interaction	  of	   ribosomal	  protein	  L1	  with	  RNA.	   Journal	  of	  Molecular	  
Biology,	  355(4),	  747–759.	  
Nikulin,	  A.,	  Eliseikina,	   I.,	  Tishchenko,	  S.,	  Nevskaya,	  N.,	  Davydova,	  N.,	  Platonova,	  O.,	  Piendl,	  W.,	  
Selmer,	   M.,	   Liljas,	   A.,	   Drygin,	   D.,	   Zimmermann,	   R.,	   Garber,	   M.	   and	   Nikonov,	   S.	   (2003).	  
Structure	  of	   the	  L1	  protuberance	   in	   the	   ribosome.	  Nature	  Structural	  Biology,	  10(2),	  104–
108.	  
Nomura,	  M.	  (1999).	  Regulation	  of	  Ribosome	  Biosynthesis	  in	  Escherichia	  coli	  and	  Saccharomyces	  
cerevisiae :	  Diversity	  and	  Common	  Principles.	  Journal	  Of	  Bacteriology,	  181(22),	  6857–6864.	  
67	  
	  
Nomura,	   M.,	   &	   Gourse,	   R.	   (1984).	   Regulation	   of	   the	   synthesis	   of	   ribosomes	   and	   ribosomal	  
components.	  Annual	  Review	  of	  Biochemistry,	  53,	  75–117.	  
Nomura,	   M.,	   Yates,	   J.,	   &	   Dean,	   D.	   (1980).	   Feedback	   regulation	   of	   ribosomal	   protein	   gene	  
expression	  in	  Escherichia	  coli:	  structural	  homology	  of	  ribosomal	  RNA	  and	  ribosomal	  protein	  
mRNA.	  PNAS,	  77(12),	  7084–7088.	  
Parmley,	   S.,	   &	   Smith,	   G.	   (1988).	   Antibody-­‐selectable	   filamentous	   fd	   phage	   vectors:	   affinity	  
purification	  of	  target	  genes.	  Gene,	  73(2),	  305–318.	  
Philippe,	   C.,	   Portier,	   C.,	   Mougel,	   M.,	   Grunberg-­‐Manago,	   M.,	   Ebel,	   J.,	   Ehresmann,	   B.,	   &	  
Ehresmann,	   C.	   (1990).	   Target	   site	   of	   Escherichia	   coli	   ribosomal	   protein	   S15	   on	   its	  
messenger	   RNA.	   Conformation	   and	   interaction	   with	   the	   protein.	   Journal	   of	   Molecular	  
Biology,	  211(2),	  415–426.	  
Ramakrishnan,	   V.	   (2002).	   Ribosome	   structure	   and	   the	  mechanism	   of	   translation.	  Cell,	   108(4),	  
557–572.	  
Recht,	  M.,	  &	  Williamson,	  J.	   (2001).	  Thermodynamics	  and	  Kinetics	  of	  Central	  Domain	  Assembly.	  
Cold	  Spring	  Harbor	  Symposia	  on	  Quantitative	  Biology,	  66,	  591–598.	  
Roberts,	   M.	   C.	   (2005).	   Update	   on	   acquired	   tetracycline	   resistance	   genes.	   FEMS	  Microbiology	  
Letters,	  245(2),	  195–203.	  
Rodi,	  D.,	  &	  Makowski,	  L.	  (1999).	  Phage-­‐display	  technology-­‐-­‐finding	  a	  needle	  in	  a	  vast	  molecular	  
haystack.	  Current	  Opinion	  in	  Biotechnology,	  10(1),	  87–93.	  
Rose,	  M.,	  &	  Botstein,	  D.	  (1983).	  Construction	  and	  use	  of	  gene	  fusions	  to	  lacZ	  (beta-­‐galactosidase)	  
that	  are	  expressed	  in	  yeast.	  Methods	  in	  Enzymology,	  101,	  167–180.	  
Schlax,	   PJ.,	   Xavier,	   KA,	   Gluick,	   TC.,	   &	   Draper,	   DE.	   (2001).	   Translational	   repression	   of	   the	  
Escherichia	  coli	  alpha	  operon	  mRNA:	  importance	  of	  an	  mRNA	  conformational	  switch	  and	  a	  
ternary	  entrapment	  complex.	  The	  Journal	  of	  Biological	  Chemistry,	  276(42),	  38494–38501.	  
Schlünzen,	  F.,	  Zarivach,	  R.,	  Harms,	  J.,	  Bashan,	  A,	  Tocilj,	  A,	  Albrecht,	  R.,	  Yonath,	  A.	  and	  Franceschi,	  
F.	   (2001).	   Structural	   basis	   for	   the	   interaction	   of	   antibiotics	  with	   the	   peptidyl	   transferase	  
centre	  in	  eubacteria.	  Nature,	  413(6858),	  814–21.	  
Scott,	   J.,	   &	   Smith,	   G.	   (1990).	   Searching	   for	   peptide	   ligands	   with	   an	   epitope	   library.	   Science,	  
249(4967),	  386–90.	  
Scott,	   L.,	   &	   Williamson,	   J.	   (2001).	   Interaction	   of	   the	   Bacillus	   stearothermophilus	   Ribosomal	  




Scott,	   L.,	   &	  Williamson,	   J.	   (2005).	   The	   Binding	   Interface	   between	   Bacillus	   stearothermophilus	  
Ribosomal	   Protein	   S15	   and	   its	   5’-­‐Translational	   Operator	   mRNA.	   Journal	   of	   Molecular	  
Biology,	  351(2),	  280–290.	  
Serganov,	   A.,	   Polonskaia,	   A.,	   Ehresmann,	   B.,	   Ehresmann,	   C.,	   &	   Patel,	   DJ.	   (2003).	   Ribosomal	  
protein	   S15	   represses	   its	   own	   translation	   via	   adaptation	   of	   an	   rRNA-­‐like	   fold	   within	   its	  
mRNA.	  EMBO	  Journal,	  22(8),	  1898–1908.	  
Shajani,	   Z.,	   Sykes,	   MT.,	   &	   Williamson,	   JR.	   (2011).	   Assembly	   of	   bacterial	   ribosomes.	   Annual	  
Review	  of	  Biochemistry,	  80,	  501–26.	  
Sidhu,	   SS.	   (2000).	   Phage	   display	   in	   pharmaceutical	   biotechnology.	   Current	   Opinion	   in	  
Biotechnology,	  11(6),	  610–616.	  
Smith,	   G.	   P.	   (1985).	   Filamentous	   fusion	   phage:	   novel	   expression	   vectors	   that	   display	   cloned	  
antigens	  on	  the	  virion	  surface.	  Science,	  228(4705),	  1315–7.	  
Stelzl,	  U.,	   Zengel,	   JM.,	   Tovbina,	  M.,	  Walker,	  M.,	  Nierhaus,	   KH.,	   Lindahl,	   L.,	  &	  Patel,	  DJ.	   (2003).	  
RNA-­‐structural	  mimicry	   in	   Escherichia	   coli	   ribosomal	   protein	   L4-­‐dependent	   regulation	   of	  
the	  S10	  operon.	  The	  Journal	  of	  Biological	  Chemistry,	  278(30),	  28237–28245.	  
Weinberg,	  Z.,	  Barrick,	   J.	   E.,	   Yao,	  Z.,	  Roth,	  A.,	  Kim,	   J.	  N.,	  Gore,	   J.,	  Wang,	   J.,	   Lee,	  ER.,	  Block,	  KF.,	  
Sudarsan,	  N.,	  Neph,	  S.,	  Tompa,	  M.,	  Ruzzo,	  WL.	  and	  Breaker,	  RR.	  (2007).	  Identification	  of	  22	  
candidate	  structured	  RNAs	  in	  bacteria	  using	  the	  CMfinder	  comparative	  genomics	  pipeline.	  
Nucleic	  Acids	  Research,	  35(14),	  4809–4819.	  
Weinberg,	   Z.,	   Wang,	   JX.,	   Bogue,	   J.,	   Yang,	   J.,	   Corbino,	   K.,	   Moy,	   RH.,	   &	   Breaker,	   RR.	   (2010).	  
Comparative	  genomics	  reveals	  104	  candidate	  structured	  RNAs	  from	  bacteria,	  archaea,	  and	  
their	  metagenomes.	  Genome	  Biology,	  11(3),	  31.	  
Wilkinson,	   KA,	  Merino,	   EJ.,	   &	  Weeks,	   KM.	   (2006).	   Selective	   2’-­‐hydroxyl	   acylation	   analyzed	   by	  
primer	   extension	   (SHAPE):	   quantitative	   RNA	   structure	   analysis	   at	   single	   nucleotide	  
resolution.	  Nature	  Protocols,	  1(3),	  1610–6.	  
Yao,	  Z.,	  Barrick,	   J.,	  Weinberg,	  Z.,	  Neph,	  S.,	  Breaker,	  RR,	  &	  Tompa,	  M.	   (2007).	  A	  Computational	  
Pipeline	  for	  High-­‐	  Throughput	  Discovery	  of	  cis-­‐Regulatory	  Noncoding	  RNA	  in	  Prokaryotes.	  
PLoS	  Computational	  Biology,	  3(7),	  12.	  
Yonath,	  A.	  (2005).	  Antibiotics	  targeting	  ribosomes:	  resistance,	  selectivity,	  synergism	  and	  cellular	  
regulation.	  Annual	  Review	  of	  Biochemistry,	  74,	  649–679.	  
Zengel,	  JM.,	  &	  Lindahl,	  L.	  (1994).	  Diverse	  mechanisms	  for	  regulating	  ribosomal	  protein	  synthesis	  
in	  Escherichia	  coli.	  Progress	  in	  Nucleic	  Acid	  Research	  and	  Molecular	  Biology,	  47,	  331–370.	  
	  
	  
